Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AC092442.1		ENSG00000284684			4	6064977-6070162	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	16	"blood: 1.5"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in some"		"gdTCR: 1.5;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Region enriched"	"Detected in single"	15	"hypothalamus: 0.7"																																	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0										
CD8A	CD8	ENSG00000153563	"CD8a molecule"	P01732	2	86784610-86808396	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"blood: 82.2;lymphoid tissue: 262.3"	"Cell line enriched"	"Detected in some"	4	"MOLT-4: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"MAIT T-cell: 36.7;memory CD8 T-cell: 82.2;naive CD8 T-cell: 77.8"	"Lineage enriched"	"Detected in many"	20	"T-cells: 82.2"					"Low region specificity"	"Detected in all"			"CAB000012, HPA037756, CAB075722"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	500000	500000	"Plasma membrane"		"CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: "	"unprognostic (1.29e-3)"	"prognostic favourable (4.54e-4)"	"unprognostic (9.26e-3)"	"prognostic favourable (6.15e-6)"	"unprognostic (7.28e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.91e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.56e-2)"	2.4	1.4	1.4	7.4	2.8	6.8	1.5	1.4	1.2	2.1	5.3	0.8	0.8	4.2	1.5	2.1	2.0	2.1	4.5	1.6	1.2	1.6	1.3	2.1	6.0	23.8	1.0	0.5	1.7	1.2	0.0	0.9	0.6	0.7	2.3	1.9	1.8	3.0	1.1	0.8	0.7	12.2	0.7	1.7	46.4	5.4	1.0	0.5	262.3	2.2	1.6	8.1	3.8	1.9	0.0	0.1	0.6	0.1	4.0	82.2	17.4	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.8	17.4	1.1	0.6	0.3	0.1	0.9	3.9	0.0	0.4	0.9	2.4	0.2	0.1	0.0	0.4	0.5	0.0	0.0	0.6	0.1	0.0	0.1	0.3	0.9	0.0	0.0	0.1	0.1	0.1	0.0	4.8	0.0	36.7	0.0	0.3	82.2	0.0	0.0	0.3	77.8	0.6	4.0	0.1	0.1	0.1	17.4	1.4	2.8	1.4	1.2	1.2	1.6	1.0	0.5	0.7	0.5
PSMB11	beta5t	ENSG00000222028	"Proteasome subunit beta 11"	A5LHX3	14	23042167-23044276	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 32.7"	"Cell line enriched"	"Detected in single"	4	"PC-3: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Region enriched"	"Detected in single"	7	"olfactory region: 2.3"	"Not detected"	"Not detected"			"HPA028967, HPA056970"	Enhanced									"HPA028967: AB_2732444, HPA056970: AB_2683293"				"unprognostic (7.96e-2)"	"unprognostic (2.77e-1)"													0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	32.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0
CCR7	"BLR2, CD197, CDw197, CMKBR7, EBI1"	ENSG00000126353	"C-C motif chemokine receptor 7"	P32248	17	40553769-40565472	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"blood: 252.3;lymphoid tissue: 110.6"	"Cell line enriched"	"Detected in some"	79	"HDLM-2: 171.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 252.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 252.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003796, HPA031383, HPA074467"	Enhanced		Approved	Mitochondria				Mitochondria		"CAB003796: AB_562261, HPA031383: , HPA074467: AB_2686693"	"prognostic favourable (3.84e-4)"	"prognostic favourable (8.03e-6)"	"unprognostic (2.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.35e-3)"	"prognostic favourable (7.61e-7)"	"unprognostic (2.71e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.68e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavourable (7.72e-4)"	"unprognostic (1.02e-1)"	"unprognostic (7.95e-2)"	2.8	0.4	0.2	26.0	0.2	5.2	1.7	0.2	0.3	2.2	1.2	0.3	0.8	0.3	1.2	0.5	1.4	2.3	2.0	1.9	0.2	0.2	1.5	1.7	3.4	110.6	0.3	0.2	1.5	0.3	0.0	1.0	1.0	0.4	1.3	2.1	0.7	8.4	0.2	0.2	1.1	16.2	0.2	0.4	20.3	1.8	1.2	0.3	57.1	2.0	1.2	53.8	4.2	1.3	58.8	2.9	2.3	0.3	44.1	252.3	109.3	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	171.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.9	0.1	1.1	0.2	0.0	0.0	1.1	0.3	0.2	3.1	0.1	3.6	37.2	53.3	15.3	0.2	58.8	252.3	133.9	2.3	44.1	0.2	2.9	30.3	109.3	0.2	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.4	0.3
CD8B2	CD8BP	ENSG00000254126	"CD8b2 molecule"		2	106487364-106544297	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	10	"blood: 20.6;lymphoid tissue: 35.1"	"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 91.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	9	"memory CD8 T-cell: 12.0;naive CD8 T-cell: 20.6"	"Lineage enriched"	"Detected in many"	15	"T-cells: 20.6"																				"unprognostic (9.34e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.54e-2)"		"unprognostic (1.18e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.90e-2)"	"unprognostic (9.67e-3)"	0.1	0.0	0.1	1.1	0.4	0.2	0.0	0.6	0.6	1.9	0.3	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.2	0.0	0.7		2.8	0.4	0.4	5.3	0.0	0.0	0.2	0.0	2.8	0.8	0.1	0.7	1.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.9	1.6	0.0	0.0	35.1	0.0	0.3	9.0	0.3	0.0	0.0	0.0	1.3	0.0	0.2	20.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	9.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.0	1.7	0.0	0.0	12.0	0.0	0.0	0.0	20.6	0.1	0.2	0.0	0.0	0.0	5.8										
TIMD4		ENSG00000145850	"T cell immunoglobulin and mucin domain containing 4"	Q96H15	5	156919282-156963255	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 32.0;lymphoid tissue: 83.9;testis: 58.9"	"Group enriched"	"Detected in some"	18	"U-266/70: 45.7;U-266/84: 12.4"	"Cancer enriched"	"Detected in some"	10	"renal cancer: 6.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 2.3;memory CD8 T-cell: 4.5;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.0;T-reg: 6.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 6.4"									"HPA015625, CAB026027"	Approved					18000000	18000000			"CAB026027: , HPA015625: AB_1858018"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.90e-2)"	"prognostic favourable (3.37e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.08e-2)"	6.7	0.4	0.4	3.5	0.4	5.3	0.5	0.4	0.4	0.4	1.3	0.0	0.0	0.0	0.4	1.0	1.5	0.4	0.3	0.8	0.4	0.4	1.7	32.0	0.6	83.9	0.5	0.0	0.4	0.4	0.0	0.4	2.8	0.0	1.1	0.1	0.0	6.5	0.0	0.7	0.4	1.1	0.2	0.5	12.5	0.4	58.9	0.0	21.7	0.8	0.2	8.5	5.3	0.4	0.4	0.0	0.0	0.0	0.0	6.4	1.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	45.7	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	2.3	4.5	0.0	0.0	3.0	3.0	0.0	0.0	0.0	0.0	6.4	1.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.0
CD3D	T3D	ENSG00000167286	"CD3d molecule"	P04234	11	118338954-118342744	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 108.7;lymphoid tissue: 181.4"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 152.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	53	"gdTCR: 105.6;MAIT T-cell: 68.6;memory CD4 T-cell: 88.1;memory CD8 T-cell: 97.6;naive CD4 T-cell: 78.8;naive CD8 T-cell: 98.6;T-reg: 108.7"	"Lineage enriched"	"Detected in many"	63	"T-cells: 108.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB013055	Enhanced									"CAB013055: "	"prognostic favourable (3.00e-4)"	"prognostic favourable (8.46e-5)"	"unprognostic (1.05e-2)"	"prognostic favourable (1.73e-7)"	"unprognostic (6.00e-2)"	"prognostic favourable (1.70e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (3.07e-5)"	"unprognostic (9.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.66e-2)"	"prognostic favourable (6.16e-4)"	2.6	0.8	0.5	17.4	0.7	4.8	1.7	0.5	0.7	1.3	4.1	0.7	0.8	4.1	1.2	1.6	3.2	1.9	2.9	1.0	0.7	0.4	2.6	1.9	6.1	40.8	0.9	0.5	1.0	1.2	0.0	0.7	0.8	0.7	2.2	4.3	1.1	9.0	0.8	0.7	1.3	19.3	1.0	1.5	28.6	4.4	0.8	0.5	181.4	2.7	2.8	32.6	5.7	2.4	0.5	0.3	1.7	0.3	0.2	108.7	64.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	152.7	28.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.2	105.6	0.2	68.6	0.5	88.1	97.6	0.3	0.2	78.8	98.6	1.7	0.2	0.3	0.3	108.7	64.9	0.5	0.7	0.5	0.7	0.7	0.4	0.9	0.5	0.7	0.5
CCR8	"CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1"	ENSG00000179934	"C-C motif chemokine receptor 8"	P51685	3	39329706-39333511	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"blood: 19.8;lymphoid tissue: 19.3;urinary bladder: 5.3"	"Cell line enriched"	"Detected in some"	22	"HDLM-2: 48.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 19.8"	"Lineage enriched"	"Detected in single"	30	"T-cells: 19.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042383	Enhanced									"HPA042383: AB_2732497"	"unprognostic (2.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.63e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.37e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.65e-8)"	"unprognostic (7.96e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.14e-1)"	0.3	0.2	0.2	3.1	0.2	0.0	0.3	0.2	0.2	0.3	0.5	0.1	0.1	0.0	0.3	0.1	0.8	0.1	2.1	0.2	0.2	0.2	0.5	0.3	1.4	2.8	0.1	0.1	0.2	0.3	0.0	0.2	0.1	0.1	0.4	1.3	0.1	0.5	0.1	0.2	1.0	1.2	0.1	0.4	1.7	0.8	0.3	0.1	19.3	0.4	1.2	3.5	5.3	0.3	0.0	0.0	0.0	0.0	0.6	19.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	19.8	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447681	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 17.6;lymphoid tissue: 62.3"	"Group enriched"	"Detected in some"	6	"HEL: 14.6;MOLT-4: 29.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"gdTCR: 6.9;MAIT T-cell: 12.1;memory CD4 T-cell: 15.1;memory CD8 T-cell: 13.1;naive CD4 T-cell: 17.6;naive CD8 T-cell: 12.8;T-reg: 13.6"	"Lineage enriched"	"Detected in many"	15	"T-cells: 17.6"	"Region enriched"	"Detected in single"	13	"hippocampal formation: 0.5"	"Low region specificity"	"Detected in all"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"	1.1	0.7	0.3	19.7	0.3	2.6	0.8	0.3	0.3	0.9	2.8	0.1	0.0	1.9	0.8	0.8	1.2	1.3	3.2	1.1	0.3	0.4	1.4	1.1	6.0	23.1	0.4	0.0	0.7	0.6	0.0	0.6	0.4	0.3	1.2	1.0	1.1	5.0	0.2	0.3	0.5	5.9	0.6	0.7	10.8	2.2	0.4	0.0	62.3	1.4	1.1	14.1	2.6	1.1	0.0	0.0	0.3	0.0	1.1	17.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	14.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	29.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	12.1	0.0	15.1	13.1	0.0	0.0	17.6	12.8	0.3	1.1	0.0	0.0	13.6	5.1	0.3	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.3	0.0
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703750	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6"	"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 12.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"	"Region enriched"	"Detected in single"	18	"cerebellum: 1.1"	"Low region specificity"	"Detected in all"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	9.2	4.1	0.0	0.0	0.0	0.7	9.3	62.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	48.6	0.0	0.1	3.1	0.0	1.2	0.8	0.1	0.1	0.2	3.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	1.4	68.9	0.6	3.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CENPA	"CenH3, CENP-A"	ENSG00000115163	"Centromere protein A"	P49450	2	26764289-26801067	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 53.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.6"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB008371, HPA073086"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB008371: AB_591074, HPA073086: "	"unprognostic (3.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (2.88e-8)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (1.69e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (1.30e-4)"	"unprognostic (4.21e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.07e-1)"	1.2	0.9	0.2	12.1	0.2	3.5	3.0	0.2	0.2	1.3	3.5	0.4	0.3	5.3	0.9	1.5	8.5	0.1	1.2	1.5	0.2	0.3	0.8	0.7	1.4	8.2	0.3	0.0	0.5	0.7	0.0	0.3	3.1	0.3	0.5	3.2	0.1	1.7	0.0	0.3	4.5	3.6	0.8	0.3	4.9	1.8	7.8	0.0	53.7	0.4	9.2	10.0	1.3	2.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	30.8	7.1	11.1	6.1	0.8	1.8	9.2	9.6	7.3	13.0	11.1	5.1	10.1	9.3	6.2	3.4	9.1	9.9	5.1	12.8	27.5	9.6	15.7	3.2	8.6	0.2	9.1	17.5	0.1	0.6	5.1	7.1	6.7	12.7	19.2	10.2	10.4	13.1	14.0	9.9	13.1	15.6	19.8	10.2	5.7	1.4	9.5	9.5	9.2	10.2	7.5	6.1	9.7	4.7	8.0	20.3	9.5	15.8	19.2	19.0	37.9	3.9	18.8	15.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.0	0.3	0.0
C20orf204	"DKFZp434G015, FLJ27267, LINC00176, NCRNA00176, PRR17"	ENSG00000196421	"Chromosome 20 open reading frame 204"		20	64034344-64039962	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Group enriched"	"Detected in some"	6	"blood: 8.2;brain: 11.2;lymphoid tissue: 19.1"	"Cell line enriched"	"Detected in some"	6	"Hep G2: 32.0"	"Cancer enriched"	"Detected in some"	6	"ovarian cancer: 7.2"					"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 8.2;naive CD8 T-cell: 6.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 8.2"	"Low region specificity"	"Detected in many"																		"unprognostic (2.84e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.20e-3)"	"unprognostic (4.43e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.49e-6)"	"unprognostic (5.83e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.79e-4)"	1.3	0.0	0.0	0.7	0.0	0.2	0.0	11.2	0.0	0.7	1.2	0.0	0.3	0.6	0.1	2.0	0.2	0.7	1.0	1.1	0.0		0.0	0.8	1.2	9.8	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.6	0.0	2.3	0.1	0.0	1.2	0.4	0.8	0.0	19.1	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.8	8.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.7	1.1	0.0	0.0	8.2	6.6	0.4	0.8	0.0	0.0	1.7	0.4										
GZMH	"CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2"	ENSG00000100450	"Granzyme H"	P20718	14	24606480-24609699	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 134.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;RPMI-8226: 2.0;THP-1: 1.4;U-266/70: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdTCR: 134.9;memory CD4 T-cell: 41.8;memory CD8 T-cell: 109.7;naive CD8 T-cell: 102.7"	"Lineage enriched"	"Detected in many"	8	"T-cells: 134.9"					"Low region specificity"	"Detected in all"			HPA029200	Enhanced				"Secreted to blood"					"HPA029200: AB_10602908"	"unprognostic (3.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.35e-2)"	"prognostic favourable (2.00e-6)"	"unprognostic (8.80e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.77e-3)"	3.6	3.1	1.1	5.0	1.2	16.5	3.6	0.5	1.0	1.9	3.1	0.4	0.2	0.9	1.0	2.7	2.6	1.8	8.1	4.8	1.0	1.1	1.7	3.6	16.4	11.5	2.6	1.3	3.0	1.1	0.0	3.7	1.6	1.2	4.5	1.1	5.1	5.4	4.2	4.5	0.8	2.2	2.0	3.1	22.6	2.5	2.5	0.7	0.2	2.5	3.4	6.4	5.1	1.9	0.4	3.2	1.8	0.3	17.6	134.9	82.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.4	0.9	1.8	0.2	0.1	134.9	0.2	2.4	0.4	41.8	109.7	0.2	0.2	13.9	102.7	1.5	17.6	0.3	3.2	0.3	82.9	1.1	1.2	0.5	1.0	1.0	1.1	2.6	1.3	1.2	0.7
SIRPG	"bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma"	ENSG00000089012	"Signal regulatory protein gamma"	Q9P1W8	20	1629152-1657779	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 60.1;lymphoid tissue: 44.0"	"Cell line enhanced"	"Detected in some"		"NB-4: 16.7;RT4: 4.5;THP-1: 2.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 60.1"	"Lineage enriched"	"Detected in many"	6	"T-cells: 60.1"																				"unprognostic (3.35e-3)"	"unprognostic (4.09e-3)"	"unprognostic (7.32e-3)"	"prognostic favourable (1.05e-6)"	"unprognostic (4.23e-3)"	"prognostic favourable (2.24e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.30e-2)"	"prognostic favourable (7.36e-7)"	"unprognostic (1.62e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (1.47e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.95e-3)"	0.8	0.4	0.3	11.7	0.3	1.5	0.5	0.3	0.4	0.7	2.3	0.1	0.4	0.9	0.5	0.6	1.4	0.7	2.1	0.4	0.3	0.3	1.1	1.1	1.4	20.5	0.3	0.1	0.7	0.4	0.0	0.3	0.4	0.2	0.9	1.8	0.6	4.6	0.9	0.4	0.4	8.8	0.6	0.4	14.0	1.6	0.4	0.1	44.0	1.3	0.7	21.3	2.9	0.8	0.1	1.1	1.0	0.2	9.5	60.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.1	0.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.1	0.2	0.1	12.3	0.1	34.1	0.1	38.4	29.0	0.1	0.1	40.5	33.3	1.0	9.5	0.1	1.1	60.1	16.7	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.2	0.1
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648193-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 29.2;intestine: 8.7;lymphoid tissue: 33.7"	"Cell line enriched"	"Detected in single"	72	"MOLT-4: 22.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 9.4;MAIT T-cell: 22.9;memory CD4 T-cell: 29.2;naive CD4 T-cell: 28.1"	"Lineage enriched"	"Detected in single"	58	"T-cells: 29.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045827	Enhanced				"Secreted to blood"					"HPA045827: AB_10959606"	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"	2.0	0.5	0.3	22.4	0.3	1.4	1.2	0.3	0.3	2.0	3.3	0.1	0.0	1.7	1.5	1.3	1.6	1.6	2.6	1.1	0.4	0.4	1.6	1.1	4.0	14.6	0.4	0.0	0.7	0.6	0.0	0.4	0.2	0.3	1.0	3.1	1.0	4.9	1.3	0.4	1.1	8.7	0.5	0.6	9.9	1.7	0.6	0.1	33.7	1.4	2.0	26.1	3.0	1.4	0.0	0.0	0.5	0.0	0.2	29.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	9.4	0.0	22.9	0.0	29.2	4.1	0.0	0.0	28.1	0.2	0.5	0.2	0.0	0.0	3.3	4.7	0.3	0.3	0.3	0.3	0.4	0.4	0.4	0.0	0.3	0.1
BFSP2	"CP47, CP49, LIFL-L, phakinin"	ENSG00000170819	"Beaded filament structural protein 2"	Q13515	3	133399995-133475222	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"blood: 12.7"	"Group enriched"	"Detected in some"	7	"Daudi: 5.5;U-698: 6.5"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"T-reg: 12.7"	"Lineage enriched"	"Detected in single"	48	"T-cells: 12.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA038464, HPA062959"	Enhanced		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038464: AB_10672746, HPA062959: AB_2684912"	"unprognostic (1.58e-3)"	"unprognostic (7.47e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.04e-5)"	"unprognostic (8.13e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.21e-2)"	0.0	0.0	0.1	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.8	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	1.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCR4	"CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5"	ENSG00000183813	"C-C motif chemokine receptor 4"	P51679	3	32951574-32956349	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 28.9;lymphoid tissue: 57.1"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 65.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 28.9"	"Lineage enriched"	"Detected in single"	48	"T-cells: 28.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031613	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA031613: AB_10601096"	"unprognostic (4.63e-3)"	"unprognostic (8.70e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.59e-7)"	"unprognostic (3.02e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.40e-1)"	1.5	0.6	0.3	12.6	0.4	1.5	1.1	0.3	0.3	1.1	1.1	0.1	0.7	0.4	1.0	0.6	1.6	0.8	3.8	0.8	0.3	0.3	1.8	0.9	6.0	24.1	0.3	0.0	0.5	0.5	0.5	0.5	0.1	0.1	1.5	1.2	0.8	4.3	0.2	1.8	2.2	5.0	0.4	0.4	10.2	1.3	2.7	0.0	57.1	1.3	2.8	29.7	8.6	1.1	0.2	0.2	0.5	0.1	0.1	28.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	65.5	0.0	3.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.2	0.1	0.2	0.1	6.0	1.8	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.2	28.9	0.8	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	0.1	0.0
CD8B	CD8B1	ENSG00000172116	"CD8b molecule"	P10966	2	86815339-86861924	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 132.1;lymphoid tissue: 61.5"	"Cell line enriched"	"Detected in some"	55	"RPMI-8226: 154.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory CD8 T-cell: 73.5;naive CD8 T-cell: 132.1"	"Lineage enriched"	"Detected in many"	40	"T-cells: 132.1"									"CAB004353, HPA029164"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"CAB004353: AB_627211, HPA029164: "	"unprognostic (1.83e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-2)"	"prognostic favourable (7.88e-7)"	"unprognostic (6.23e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.50e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.60e-1)"	"prognostic unfavourable (7.11e-6)"	"unprognostic (7.84e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.33e-2)"	1.2	0.7	1.0	5.3	1.0	3.9	1.0	1.3	1.3	21.2	1.1	1.0	1.0	2.5	1.2	1.0	1.0	1.1	1.8	1.0	1.0	1.8	1.0	1.0	2.7	14.4	1.7	1.0	1.3	1.0	6.4	7.4	1.0	2.2	1.3	1.3	1.0	1.0	1.0	1.0	0.9	11.4	1.0	1.5	12.7	2.3	1.0	1.0	61.5	1.5	1.0	8.1	1.8	1.3	0.1	0.1	3.2	0.1	0.1	132.1	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	154.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	3.2	0.1	0.0	2.0	0.1	10.0	0.0	0.2	73.5	0.0	0.1	0.5	132.1	0.7	0.1	0.1	0.1	0.2	36.3	1.0	1.0	1.3	1.3	1.0	1.8	1.7	1.0	2.2	1.0
IL21	"IL-21, Za11"	ENSG00000138684	"Interleukin 21"	Q9HBE4	4	122612628-122621069	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	4	"HeLa: 4.2;Karpas-707: 1.1;SiHa: 3.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	16	"memory CD4 T-cell: 2.2;T-reg: 1.0"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"													"unprognostic (2.42e-1)"						"unprognostic (2.12e-1)"	"unprognostic (6.80e-2)"			0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	3.5			0.1		7.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1										
ZNF683	"Hobit, MGC33414"	ENSG00000176083	"Zinc finger protein 683"	Q8IZ20	1	26361634-26374522	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 47.7;testis: 39.4"	"Cell line enriched"	"Detected in some"	5	"NB-4: 6.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"gdTCR: 47.7;memory CD8 T-cell: 30.6"	"Lineage enriched"	"Detected in many"	18	"T-cells: 47.7"					"Not detected"	"Not detected"			HPA023865	Uncertain									"HPA023865: AB_2671333"	"unprognostic (3.95e-3)"	"unprognostic (5.58e-3)"	"unprognostic (5.83e-2)"	"prognostic favourable (2.90e-5)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-4)"	"unprognostic (7.90e-2)"	"unprognostic (5.05e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.54e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-2)"	"prognostic favourable (3.45e-5)"	0.3	0.2	0.3	0.2	0.3	1.0	0.5	0.2	0.5	1.7	0.3	0.3	0.0	0.0	2.0	1.0	1.2	1.0	1.0	0.6	0.3	0.3	0.4	0.4	4.8	1.0	0.4	0.6	1.2	1.1	0.0	0.4	0.7	0.6	1.2	0.2	0.9	8.2	1.6	0.2	0.4	0.4	1.3	1.2	1.2	2.1	39.4	0.2	7.1	0.8	1.1	1.4	0.6	0.6	0.0	0.1	0.3	0.8	2.7	47.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	6.7	0.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	1.4	0.3	0.0	0.0	0.0	47.7	0.0	0.1	0.0	10.3	30.6	0.0	0.0	4.0	18.1	0.3	2.7	0.8	0.1	0.2	4.9	0.3	0.3	0.2	0.5	0.3	0.3	0.4	0.6	0.6	0.2
VCAM1	CD106	ENSG00000162692	"Vascular cell adhesion molecule 1"	P19320	1	100719742-100739045	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"kidney: 69.6;lymphoid tissue: 129.2"	"Group enriched"	"Detected in some"	5	"HHSteC: 56.9;HSkMC: 38.0"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 89.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"gdTCR: 1.3;memory CD8 T-cell: 2.9;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000154, HPA034796, HPA069867"	Enhanced		Approved	"Cell Junctions"		960000000	960000000	"Cell Junctions"		"CAB000154: , HPA034796: , HPA069867: AB_2686215"	"unprognostic (2.96e-1)"	"prognostic favourable (3.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (7.19e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.55e-2)"	10.9	18.1	1.5	20.2	3.2	1.3	5.2	0.9	1.1	3.7	5.0	3.3	1.4	3.3	4.9	4.5	5.3	4.9	6.8	7.2	1.7	2.3	69.6	11.8	9.8	26.8	2.8	1.7	11.1	6.6	10.6	3.5	10.9	4.2	8.3	5.5	15.3	4.9	1.1	4.7	1.8	6.3	4.2	3.7	129.2	3.0	2.5	1.6	13.3	3.5	2.8	20.9	8.2	2.8	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.2	0.1	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	8.2	0.0	0.0	0.0	0.0	56.9	0.0	0.0	38.0	0.0	10.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	2.9	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	3.2	0.9	1.1	1.7	2.3	2.8	1.7	4.2	1.6
TIGIT	"DKFZp667A205, FLJ39873, VSIG9, VSTM3"	ENSG00000181847	"T cell immunoreceptor with Ig and ITIM domains"	Q495A1	3	114276913-114310288	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 49.8;lymphoid tissue: 25.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.8;Karpas-707: 1.6;NTERA-2: 1.8;U-266/84: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 49.8"	"Lineage enriched"	"Detected in many"	11	"T-cells: 49.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.24e-2)"	"prognostic favourable (5.43e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.22e-6)"	"unprognostic (9.84e-2)"	"prognostic favourable (3.96e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.50e-4)"	"unprognostic (3.51e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.62e-2)"	"unprognostic (6.18e-3)"	1.4	0.3	0.4	20.2	0.7	0.9	1.1	0.2	0.3	0.5	1.2	0.2	1.2	0.8	1.4	1.1	1.1	0.9	3.8	0.8	0.4	0.7	1.3	1.6	5.0	25.9	0.6	0.3	0.4	0.3	0.0	0.6	0.5	0.4	1.0	1.4	1.1	4.4	1.9	0.6	0.6	8.0	0.3	1.5	13.4	2.0	0.6	0.1	4.3	1.6	1.7	20.2	4.1	1.0	0.4	0.2	0.2	0.0	4.4	49.8	5.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.5	0.3	0.0	0.0	0.1	0.0	0.5	4.8	0.0	0.1	0.9	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	1.8	0.0	0.1	1.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.5	0.1	0.1	1.3	1.8	0.0	0.9	0.3	0.0	0.0	0.0	0.0	8.5	0.0	0.9	0.4	13.6	25.0	0.0	0.2	1.5	11.4	0.2	4.4	0.0	0.2	49.8	5.4	0.4	0.7	0.2	0.3	0.4	0.7	0.6	0.3	0.4	0.1
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2-related adaptor protein 2"	O75791	22	39901082-39973721	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 138.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.4;HEL: 18.1;K-562: 17.3;MOLT-4: 47.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdTCR: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 22.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		260000	260000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.6	0.4	0.3	7.7	0.7	7.6	1.5	0.3	0.4	1.1	2.3	0.6	0.4	2.9	2.3	1.6	1.6	1.2	3.5	2.8	0.6	0.4	1.2	1.8	6.4	12.6	0.9	0.4	1.0	0.8	0.0	0.6	1.1	0.6	2.4	1.9	1.2	2.4	1.2	0.5	1.4	6.2	2.0	2.2	13.2	2.9	2.4	0.3	138.0	1.3	1.5	11.3	3.0	1.9	2.1	0.4	2.5	0.2	1.7	22.5	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	18.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.8	0.2	0.0	19.5	0.1	14.4	1.0	14.4	21.1	0.4	2.1	12.2	22.5	2.5	1.7	0.1	0.3	12.0	25.9	0.3	0.7	0.3	0.4	0.6	0.4	0.9	0.4	0.6	0.3
LIM2	"MP17, MP19"	ENSG00000105370	"Lens intrinsic membrane protein 2"	P55344	19	51379909-51387960	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"blood: 12.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;Hep G2: 1.0"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 18.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"gdTCR: 12.9"	"Lineage enriched"	"Detected in many"	8	"T-cells: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																			"unprognostic (5.25e-2)"							"unprognostic (1.09e-3)"		"unprognostic (1.21e-1)"			0.1	0.1	0.1	0.1	0.1	2.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.3	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.2	1.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.4	0.0	1.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.5	12.9	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.2	1.6	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	1.5	0.0	0.0	0.0	1.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD8 T-cell: 1.5;T-reg: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028016, HPA032023, HPA032031"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: , HPA032031: AB_2674119"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	1.3	0.7	0.4	5.4	0.6	10.8	1.3	0.4	0.5	1.2	2.8	0.3	0.1	1.7	1.0	0.6	4.0	0.4	1.5	0.6	0.4	0.4	0.8	1.0	1.6	4.4	0.4	0.1	0.6	0.5	0.6	0.7	5.4	0.2	0.6	4.2	0.2	1.1	0.1	0.4	1.6	3.3	1.4	0.4	4.6	1.1	37.2	0.1	41.2	0.9	5.7	7.5	0.9	1.6	0.7	0.3	0.0	0.4	0.6	5.2	0.7	12.5	10.7	18.4	9.2	1.1	2.3	9.0	15.8	9.8	14.9	22.3	6.6	11.1	9.5	5.9	6.0	9.8	24.2	13.3	21.6	11.5	11.6	15.2	14.1	8.1	0.0	19.9	9.5	1.0	0.4	24.2	12.9	6.8	18.1	19.4	17.2	5.0	26.6	9.1	21.2	12.4	21.1	32.4	18.4	4.2	8.7	11.5	18.0	15.0	14.4	6.5	12.2	9.1	3.7	15.0	11.2	15.4	17.7	7.1	11.1	22.0	7.6	13.2	14.5	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.8	1.5	0.3	0.1	0.0	0.3	0.0	0.6	0.0	0.0	5.2	0.7	0.4	0.6	0.4	0.5	0.4	0.4	0.4	0.1	0.2	0.1
LEF1	"TCF10, TCF1ALPHA, TCF7L3"	ENSG00000138795	"Lymphoid enhancer binding factor 1"	Q9UJU2	4	108047545-108168956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 231.5"	"Group enriched"	"Detected in some"	5	"MOLT-4: 103.2;REH: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 42.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 42.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002087, CAB019405"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"CAB019405: AB_823558, HPA002087: AB_1079245"	"unprognostic (1.03e-3)"	"unprognostic (7.36e-3)"	"unprognostic (2.97e-2)"	"prognostic favourable (1.37e-5)"	"unprognostic (9.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.47e-6)"	"unprognostic (1.12e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-2)"	0.9	13.5	3.5	9.3	5.4	7.6	2.0	1.6	3.4	3.6	1.0	2.9	0.8	0.4	6.0	3.5	3.4	5.0	2.8	0.5	4.7	5.2	2.7	0.3	2.4	25.3	4.9	1.9	1.8	0.8	0.0	1.1	7.8	3.1	2.8	1.0	1.6	3.1	0.7	0.5	2.4	3.9	2.9	4.4	7.0	0.9	8.2	2.3	231.5	2.7	1.3	20.6	4.8	3.2	0.3	0.1	0.5	0.0	8.9	42.2	9.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.8	4.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	3.2	1.2	0.0	0.0	0.0	4.0	0.6	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.5	0.1	103.2	0.0	0.3	0.2	79.7	1.5	0.0	0.4	0.2	0.5	0.9	0.0	0.0	15.2	0.4	0.0	0.0	2.2	1.8	0.0	2.6	6.7	2.8	18.3	1.3	0.0	8.8	0.0	0.0	0.0	2.6	0.0	0.5	0.1	19.7	8.8	0.0	0.3	42.2	29.2	0.5	8.9	0.0	0.1	25.7	9.5	3.5	5.4	1.6	3.4	4.7	5.2	4.9	1.9	3.1	2.3
NCAPG	"CAP-G, FLJ12450, hCAP-G, YCG1"	ENSG00000109805	"Non-SMC condensin I complex subunit G"	Q9BPX3	4	17810902-17844862	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 65.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039613	Uncertain									"HPA039613: AB_10805481"	"unprognostic (5.23e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.59e-3)"	"prognostic unfavourable (8.28e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (3.13e-6)"	"unprognostic (1.18e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.70e-2)"	"prognostic unfavourable (7.65e-5)"	"unprognostic (3.44e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	1.4	1.1	0.3	18.0	0.4	12.5	2.5	0.7	0.5	1.4	2.9	0.3	0.2	3.7	0.8	1.2	7.1	0.3	0.7	1.6	0.4	0.7	0.9	1.1	1.8	8.3	2.0	0.3	0.6	0.5	0.0	0.4	3.7	0.5	0.7	2.4	0.3	1.6	0.9	0.6	3.4	3.3	0.7	1.0	6.4	1.9	11.8	0.3	65.4	0.5	6.7	8.6	1.6	2.0	0.5	0.5	0.0	0.4	0.3	2.9	1.7	16.2	10.5	24.0	15.7	1.5	3.0	8.8	21.1	8.3	20.8	21.4	13.3	10.0	24.3	4.3	5.9	7.4	20.3	8.1	28.7	11.0	10.0	19.3	14.3	10.7	0.1	13.6	7.6	0.5	0.5	15.4	7.1	10.4	18.9	27.8	20.6	4.8	15.5	13.2	12.3	10.3	15.4	21.7	10.2	6.3	5.1	18.9	11.2	19.0	4.1	6.0	9.5	7.7	8.5	20.0	9.1	11.3	28.7	8.7	8.1	20.7	8.3	14.2	13.2	0.0	0.0	0.0	0.5	0.2	0.0	0.5	1.0	0.6	0.5	0.2	0.1	0.7	0.0	0.3	0.4	0.0	2.9	1.7	0.3	0.4	0.7	0.5	0.4	0.7	2.0	0.3	0.5	0.3
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 109.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 18.8;MOLT-4: 29.3;RPMI-8226: 12.5;U-266/70: 5.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.1"	"Group enriched"	"Detected in many"	23	"gdTCR: 11.3;MAIT T-cell: 14.5;memory CD4 T-cell: 14.5;memory CD8 T-cell: 20.5;naive CD4 T-cell: 13.1;naive CD8 T-cell: 25.2"	"Lineage enriched"	"Detected in single"	88	"T-cells: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA031422, HPA031425"	Enhanced									"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	1.4	0.6	1.9	9.6	0.8	2.4	0.8	0.2	7.1	1.0	2.8	0.1	0.5	2.2	0.9	0.9	1.2	0.8	2.4	0.5	1.8	0.6	0.9	0.9	3.6	13.2	1.1	0.1	0.9	0.6	0.0	0.4	0.2	0.5	0.9	1.3	0.8	5.2	0.9	0.3	0.5	5.0	0.8	1.5	5.8	2.0	0.4	0.4	109.6	1.3	1.6	10.4	2.3	1.2	0.0	0.0	0.2	0.0	0.0	25.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.3	0.0	14.5	0.0	14.5	20.5	0.0	0.0	13.1	25.2	0.2	0.0	0.0	0.0	0.7	7.4	1.9	0.8	0.2	7.1	1.8	0.6	1.1	0.1	0.5	0.4
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936748-203961577	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8"	"Group enriched"	"Detected in some"	100	"HEL: 5.9;MOLT-4: 15.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 18.4"	"Lineage enriched"	"Detected in single"	58	"T-cells: 18.4"	"Low region specificity"	"Detected in single"							"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"			"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"	1.5	0.3	0.2	15.6	0.2	13.8	0.7	0.2	0.2	0.8	1.2	0.0	0.2	0.5	1.2	0.5	1.1	1.2	1.6	0.5	0.2	0.2	1.0	0.8	4.0	19.4	0.3	0.0	0.6	0.3	0.0	0.4	0.1	0.1	0.7	1.1	0.7	2.9	0.0	0.2	0.6	6.2	0.3	0.4	6.1	1.0	0.6	0.0	51.8	1.4	2.4	28.9	3.0	0.9	0.0	0.0	0.0	0.0	0.3	18.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	2.9	0.0	10.5	4.6	0.0	0.0	11.0	5.0	0.0	0.3	0.0	0.0	18.4	3.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.1	0.0
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 187.6"	"Cell line enriched"	"Detected in single"	78	"MOLT-4: 64.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	30	"gdTCR: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2"	"Lineage enriched"	"Detected in many"	37	"T-cells: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: "	"prognostic favourable (6.33e-4)"	"prognostic favourable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favourable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	1.1	0.6	0.4	7.1	0.4	0.5	0.8	0.3	0.3	0.7	2.3	0.4	0.4	2.0	0.9	0.6	1.5	1.1	1.9	0.6	0.4	0.4	1.2	0.9	2.4	17.2	0.5	0.2	0.7	0.7	0.0	0.5	0.4	0.3	1.0	1.6	0.9	2.9	0.3	5.9	0.6	8.1	0.2	0.8	11.5	2.4	0.5	0.2	187.6	1.4	1.7	19.2	2.5	1.1	0.1	0.2	1.2	0.2	0.2	46.7	14.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.2	64.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.6	0.2	0.2	43.5	0.1	25.6	0.1	36.1	37.1	0.1	0.1	37.6	46.7	1.2	0.2	0.1	0.2	34.2	14.1	0.4	0.4	0.3	0.3	0.4	0.4	0.5	0.2	0.3	0.2
CD5	"LEU1, T1"	ENSG00000110448	"CD5 molecule"	P06127	11	61102395-61127852	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.3;lymphoid tissue: 96.2"	"Cell line enriched"	"Detected in single"	99	"MOLT-4: 38.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	20	"gdTCR: 12.9;MAIT T-cell: 9.3;memory CD4 T-cell: 31.2;memory CD8 T-cell: 20.6;naive CD4 T-cell: 25.9;naive CD8 T-cell: 19.5;T-reg: 36.3"	"Lineage enriched"	"Detected in many"	32	"T-cells: 36.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB015392, CAB020308, HPA043416, HPA060839"	Enhanced									"CAB015392: AB_2075324, CAB020308: , HPA043416: AB_2678472, HPA060839: "	"prognostic favourable (4.05e-4)"	"prognostic favourable (9.16e-5)"	"unprognostic (2.33e-1)"	"prognostic favourable (9.00e-5)"	"unprognostic (1.02e-2)"	"prognostic favourable (7.41e-6)"	"unprognostic (2.45e-3)"	"unprognostic (1.37e-2)"	"prognostic favourable (3.93e-4)"	"unprognostic (1.25e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (8.94e-5)"	"unprognostic (4.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.06e-1)"	2.1	0.6	0.5	19.4	0.4	6.5	1.3	0.3	0.6	1.6	2.5	0.3	0.3	1.7	1.1	1.7	1.9	1.4	3.9	0.8	0.6	1.3	1.9	1.1	7.1	28.8	0.4	0.1	1.1	0.9	0.0	0.8	0.4	0.3	1.4	1.5	1.6	15.5	1.3	0.6	1.3	10.2	0.4	0.7	13.8	4.8	1.3	0.1	96.2	1.7	2.4	42.2	5.4	1.5	1.1	1.1	0.4	0.7	0.1	36.3	14.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	12.9	0.1	9.3	0.4	31.2	20.6	0.9	1.1	25.9	19.5	0.4	0.1	0.7	1.1	36.3	14.6	0.5	0.4	0.3	0.6	0.6	1.3	0.4	0.1	0.3	0.1
KLRG1	"2F1, CLEC15A, MAFA, MAFA-L"	ENSG00000139187	"Killer cell lectin like receptor G1"	Q96E93	12	8950044-9010760	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 83.1"	"Group enriched"	"Detected in many"	5	"HEL: 23.0;HUVEC TERT2: 8.1;NTERA-2: 15.8;U-937: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdTCR: 71.3;MAIT T-cell: 83.1"	"Lineage enriched"	"Detected in many"	28	"T-cells: 83.1"	"Low region specificity"	"Detected in some"							"HPA051403, HPA076494"	Approved		Enhanced	Vesicles				Vesicles		"HPA051403: , HPA076494: "	"unprognostic (1.54e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.86e-2)"	15.4	3.9	4.4	7.3	5.8	5.6	5.7	12.3	5.0	3.2	3.5	7.1	0.8	1.7	5.6	4.2	2.2	2.6	7.7	5.1	4.4	5.8	3.2	6.4	5.5	17.3	8.3	3.4	2.7	1.9	1.5	5.6	1.5	5.5	4.8	4.7	5.6	3.5	1.8	3.1	2.2	5.0	3.9	5.5	19.0	3.6	2.2	6.8	6.8	2.9	2.3	11.1	8.3	2.6	0.5	1.3	2.4	0.6	2.9	83.1	14.0	0.1	2.2	1.2	1.7	2.0	0.4	1.1	0.3	0.3	0.2	0.7	0.7	0.7	3.1	0.1	0.3	0.2	2.8	0.3	0.3	2.2	1.4	23.0	0.3	1.2	0.5	0.7	1.2	1.4	0.3	0.3	0.0	8.1	1.0	0.3	0.1	0.5	0.5	1.6	15.8	1.5	0.9	0.7	0.0	0.3	0.3	0.3	3.1	0.7	0.4	0.9	0.2	1.0	0.5	0.5	0.7	0.4	1.0	1.0	2.7	1.7	1.4	14.5	0.2	2.4	0.3	0.2	71.3	0.4	83.1	0.5	15.8	43.4	1.3	0.5	4.3	29.9	0.9	2.9	0.6	0.5	1.2	14.0	4.4	5.8	12.3	5.0	4.4	5.8	8.3	3.4	5.5	6.8
OPN1MW3		ENSG00000269433	"Opsin 1, medium wave sensitive 3"	P0DN78	X	154257538-154271805	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	4	"blood: 2.2;skin 1: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"gdTCR: 2.2"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"																																					0.0	0.0		0.0		0.2	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	1.8	0.0	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0										
LAIR2	CD306	ENSG00000167618	"Leukocyte associated immunoglobulin like receptor 2"	Q6ISS4	19	54497879-54510687	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.8;lymphoid tissue: 19.6;pituitary gland: 7.1;placenta: 15.5"	"Group enriched"	"Detected in some"	5	"BEWO: 6.8;Hep G2: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"T-reg: 12.8"	"Lineage enriched"	"Detected in single"	21	"T-cells: 12.8"														"Secreted - unknown location"						"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.86e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.68e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.40e-5)"	"unprognostic (6.71e-2)"	0.9	0.5	0.6	5.9	1.7	1.6	0.5	0.2	1.3	0.4	0.6	1.3	0.0	0.4	0.5	1.3	0.7	0.5	1.3	0.4	1.4	3.0	0.6	0.8	3.2	12.3	0.6	0.5	0.2	0.9	0.1	7.1	15.5	1.3	0.8	1.3	0.4	0.5	0.4	0.6	0.5	1.2	0.5	1.5	6.6	1.0	1.2	0.4	19.6	0.5	0.0	2.0	0.3	0.3	0.0	0.0	0.1	0.1	0.6	12.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.7	0.3	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	3.0	2.0	0.0	0.0	0.8	2.7	0.1	0.6	0.1	0.0	12.8	1.8	0.6	1.7	0.2	1.3	1.4	3.0	0.6	0.5	1.3	0.4
CCL4	"Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4"	ENSG00000275302	"C-C motif chemokine ligand 4"	P13236	17	36103590-36105621	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 69.3;lung: 23.1;lymphoid tissue: 20.8"	"Group enriched"	"Detected in some"	23	"Karpas-707: 5.1;U-266/70: 11.2;U-266/84: 5.4"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in many"	5	"gdTCR: 69.3;MAIT T-cell: 21.8;memory CD8 T-cell: 40.6;naive CD8 T-cell: 30.5"	"Lineage enriched"	"Detected in many"	17	"T-cells: 69.3"									CAB007805	Approved				"Secreted to blood"					"CAB007805: AB_598177"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"prognostic favourable (3.54e-4)"	"prognostic favourable (1.97e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.69e-1)"	"prognostic favourable (3.97e-4)"	"unprognostic (3.45e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-2)"	2.3	2.6	0.0	3.7	0.4	9.3	5.7	0.1	3.6	0.9	2.9	1.4	0.5	0.2	1.6	0.8	1.7	1.6	4.4	3.8	0.0		1.3	5.7	23.1	20.8	1.1	0.0	3.4	0.9	0.0	0.2	4.3	0.9	1.1	1.0	3.9	1.6	1.6	0.5	0.0	0.9	1.4	1.5	10.4	2.3	0.3	0.0	1.0	1.6	2.0	4.3	1.9	0.8	1.8	0.4	4.0	0.6	3.0	69.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	5.4	0.3	0.0	0.0	0.0	1.7	0.2	4.0	69.3	0.0	21.8	0.9	7.7	40.6	0.1	1.8	2.3	30.5	1.6	3.0	0.6	0.4	0.0	11.6										
TRABD2A	"C2orf89, TIKI1"	ENSG00000186854	"TraB domain containing 2A"	Q86V40	2	84821650-84907008	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 29.3;intestine: 26.6;lymphoid tissue: 24.7;ovary: 23.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.3;HDLM-2: 18.3;HSkMC: 13.0;hTEC/SVTERT24-B: 10.7;SiHa: 10.4"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 14.4;stomach cancer: 3.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 29.3"	"Lineage enriched"	"Detected in many"	17	"T-cells: 29.3"									HPA045817	Approved				"Intracellular and membrane"					"HPA045817: AB_2679460"	"unprognostic (7.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.82e-5)"	"unprognostic (2.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.47e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.37e-1)"	1.8	0.5	0.7	24.7	1.6	2.1	6.3	0.6	3.7	0.5	23.2	0.9	0.0	2.4	0.5	0.4	0.5	1.3	0.2	0.7	0.9	0.8	0.9	0.9	3.0	11.3	0.9	3.1	23.7	0.4	0.4	0.6	2.0	0.2	0.5	26.6	1.2	3.3	0.0	0.3	1.2	9.3	1.8	0.9	3.1	0.6	0.6	0.0	6.4	0.7	0.0	6.3	0.7	0.7	1.7	0.6	0.5	0.1	1.3	29.3	5.3	0.7	0.6	0.2	0.1	7.2	7.8	24.3	1.2	1.9	3.5	6.4	0.3	2.7	0.0	0.3	3.8	0.0	1.7	0.3	5.2	18.3	0.4	0.0	5.1	0.0	0.8	0.0	0.0	13.0	0.0	10.7	4.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.1	0.0	0.1	0.2	3.4	0.4	0.0	1.2	2.2	0.0	0.0	3.0	2.0	0.0	0.0	0.1	0.0	3.3	0.1	4.0	0.3	13.1	5.0	0.6	1.7	29.3	18.2	0.5	1.3	0.0	0.6	8.5	5.3	0.7	1.6	0.6	3.7	0.9	0.8	0.9	3.1	0.2	0.0
SLC7A3	"ATRC3, CAT-3, FLJ14541"	ENSG00000165349	"Solute carrier family 7 member 3"	Q8WY07	X	70925582-70931125	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 45.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.8;HAP1: 24.5;MOLT-4: 9.6;NTERA-2: 50.3;REH: 10.5"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 43.0"	"Region enhanced"	"Detected in many"		"hypothalamus: 6.7"	"Cell type enriched"	"Detected in single"	16	"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003629	Approved									"HPA003629: AB_2190964"	"unprognostic (1.42e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.45e-2)"			"unprognostic (1.45e-2)"		"unprognostic (3.66e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.89e-1)"		"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (5.42e-4)"	"unprognostic (3.57e-2)"	0.1	0.0	1.0	0.1	1.0	1.3	1.4	0.1	2.1	2.0	0.1	1.1	0.8	0.1	9.1	6.2	0.7	2.7	0.1	0.0	1.2	6.7	0.2	0.0	0.1	0.5	0.5	0.5	1.7	0.0	0.0	0.6	0.0	1.2	10.4	0.0	0.5	0.2	9.4	0.0	0.0	0.3	4.6	0.2	0.1	5.6	2.4	0.4	45.5	0.0	0.2	0.5	4.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.2	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	50.3	0.0	10.5	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	1.0	1.0	0.1	2.1	1.2	6.7	0.5	0.5	1.2	0.4
AP000311.1		ENSG00000249209			21	33584687-33931607	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	4	"blood: 10.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 10.7"	"Not detected"	"Not detected"							"Group enriched"	"Detected in many"	7	"gdTCR: 5.4;MAIT T-cell: 7.8;memory CD4 T-cell: 7.9;memory CD8 T-cell: 8.1;naive CD4 T-cell: 7.4;naive CD8 T-cell: 6.9;T-reg: 10.8"	"Lineage enriched"	"Detected in many"	9	"T-cells: 10.8"									HPA039558	Uncertain									"HPA039558: AB_2676570"												"unprognostic (4.72e-1)"						0.4	0.4	0.5	1.4	0.6	0.0	0.4	0.8	0.6	0.6	0.5			0.9	0.6	1.8	0.5	0.6	0.3	1.2	0.4	0.4	0.4	0.9	1.0	2.5	0.4		0.7	0.4	0.0	0.3	2.3		0.9	1.1		1.6	0.0	1.2	0.9	0.9	0.0	0.4	0.4	0.9	1.6			0.3		0.0	0.5	0.3	1.1	0.7	1.2	0.4	0.3	10.8	1.2	4.0	0.4	0.1	0.1	0.2	0.0	1.4	0.7	0.0	0.2	0.1	4.4	2.2	0.0	3.5	0.2	1.9	1.0	0.2	0.0	2.7	0.2	1.1	0.2	0.1	0.4	1.8	1.3	0.5	0.0	0.2	0.2	0.0	2.3	5.1	0.0	0.9	2.5	1.0	3.4	2.4	3.5	0.8	1.4	0.0	1.3	3.7	0.4	3.8	2.4	0.3	2.3	2.4	0.0	0.2	10.7	0.3	0.2	2.9	1.7	0.6	2.9	0.8	0.0	1.2	0.4	0.3	5.4	0.3	7.8	1.0	7.9	8.1	0.3	1.1	7.4	6.9	0.6	0.3	0.4	0.7	10.8	1.2										
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191678	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 8.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.52e-6)"	"prognostic unfavourable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavourable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	1.4	0.9	0.3	11.4	0.4	16.2	0.5	0.3	0.5	1.3	3.3	0.2	0.2	2.9	0.9	1.0	8.7	0.3	1.3	0.7	0.2	0.3	1.1	0.8	2.1	10.6	0.3	0.2	0.7	0.4	0.0	0.3	3.3	0.3	0.5	4.1	0.3	1.5	0.2	0.5	1.9	4.1	1.3	0.3	6.6	2.2	13.0	0.2	65.1	0.4	6.4	11.4	1.7	2.4	1.1	0.4	0.4	0.0	1.3	8.3	1.2	37.0	14.7	38.8	17.4	0.9	3.9	12.0	21.5	14.2	31.9	30.4	12.0	20.5	21.6	11.9	12.5	23.1	24.8	17.3	41.9	25.9	12.2	22.1	13.8	10.3	0.1	21.6	13.6	0.7	0.6	14.9	7.2	35.1	17.9	21.6	29.6	17.8	27.3	11.1	20.0	15.4	21.3	37.5	9.9	10.4	12.1	19.8	11.1	22.9	8.6	8.5	19.3	8.1	13.6	14.3	37.4	13.8	24.7	5.3	11.5	28.6	10.0	15.4	22.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.1	2.3	0.4	0.1	0.5	0.2	0.4	1.3	0.0	0.0	8.3	1.2	0.3	0.4	0.3	0.5	0.2	0.3	0.3	0.2	0.3	0.2
RRM2		ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10131419	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 120.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 10.4"									HPA056994	Enhanced		Supported	Cytosol				Cytosol		"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	4.7	2.2	0.4	32.6	0.4	29.0	4.2	0.4	0.9	3.5	9.3	0.4	0.4	5.2	2.1	1.7	21.6	0.7	5.0	3.3	0.4	0.5	2.0	3.9	5.7	16.4	0.6	0.1	0.9	2.9	0.0	0.7	5.4	0.3	1.0	10.6	0.1	2.9	0.0	0.5	2.8	11.3	3.2	0.8	19.8	5.4	8.0	0.0	120.9	0.8	22.3	33.1	3.8	5.2	1.4	0.3	0.6	0.2	1.8	10.4	2.6	29.1	17.7	25.0	17.1	2.2	4.1	24.8	47.7	23.6	34.1	37.1	29.5	14.0	26.8	6.6	14.9	14.3	40.5	24.6	41.8	60.0	15.6	51.6	17.0	26.0	0.1	38.2	24.8	1.4	0.5	41.7	3.5	27.5	21.6	79.5	42.4	22.0	42.2	20.5	20.2	20.7	31.8	54.6	18.4	16.7	22.2	24.8	20.4	39.2	27.9	4.8	15.0	6.9	9.6	26.1	38.0	19.5	66.8	51.6	40.5	54.7	18.5	32.4	37.5	0.3	0.1	0.1	3.7	0.0	0.0	1.4	2.6	2.9	0.2	0.4	0.2	1.2	0.6	1.8	0.2	0.3	10.4	2.6	0.4	0.4	0.4	0.9	0.4	0.5	0.6	0.1	0.3	0.0
CCL5	"D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228"	ENSG00000271503	"C-C motif chemokine ligand 5"	P13501	17	35871491-35880793	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 169.0"	"Cell line enriched"	"Detected in some"	4	"NB-4: 71.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"gdTCR: 157.7;memory CD8 T-cell: 169.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 169.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"								"Secreted to blood"	8200000	8200000				"unprognostic (3.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (8.63e-2)"	"prognostic favourable (1.34e-5)"	"unprognostic (1.36e-3)"	"unprognostic (6.37e-3)"	"unprognostic (8.70e-2)"	"unprognostic (2.64e-2)"	"prognostic favourable (2.42e-4)"	"unprognostic (3.26e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (3.61e-7)"	"unprognostic (1.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (3.73e-2)"	3.6	2.4	0.0	28.8	0.1	17.1	2.6	0.0	0.2	6.0	14.7	1.0	0.6	7.1	5.0	7.2	5.2	1.7	20.5	7.5	0.0		2.7	4.7	29.8	33.5	2.8	0.0	5.9	2.3	0.0	0.1	4.8	1.7	7.8	4.0	8.0	5.5	6.4	2.8	0.0	38.7	2.3	2.2	38.8	6.9	1.9	0.0	12.2	1.6	5.5	27.9	11.5	0.0	1.2	1.1	9.9	0.6	40.8	169.0	106.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	2.4	2.8	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.2	0.0	0.1	11.3	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	0.0	71.3	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.0	16.7	0.0	0.0	0.0	0.1	0.0	2.1	0.7	0.1	0.0	15.3	0.1	9.9	0.6	0.7	157.7	0.4	103.8	1.2	36.7	169.0	1.1	0.7	8.8	99.3	4.6	40.8	0.5	0.9	0.5	106.5										
RASGRP1	"CalDAG-GEFII, RASGRP"	ENSG00000172575	"RAS guanyl releasing protein 1"	O95267	15	38488103-38565575	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.1;lymphoid tissue: 55.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 28.8;MOLT-4: 27.2;REH: 7.6;U-698: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039389			Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039389: AB_2732481"	"unprognostic (3.44e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.63e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.30e-2)"	1.7	1.0	5.7	9.9	17.0	7.8	1.9	33.1	18.5	1.4	1.6	0.8	0.0	2.5	1.6	1.6	6.7	4.7	2.7	1.6	6.1	3.2	5.9	1.2	4.2	20.0	3.0	6.2	0.8	2.0	0.3	1.2	4.9	22.3	1.0	2.3	1.4	2.5	1.0	0.8	7.3	3.7	0.7	1.6	8.6	4.8	2.2	1.1	55.8	1.2	1.6	16.3	4.3	2.4	1.2	0.0	0.8	0.0	2.4	10.4	1.4	0.0	0.2	0.5	0.1	0.0	0.0	0.0	2.2	0.7	1.1	0.9	2.4	0.0	6.1	0.5	0.1	0.1	1.3	0.0	1.0	28.8	1.2	0.4	0.2	0.0	0.3	0.2	0.4	0.0	0.1	0.6	0.0	0.0	0.2	1.9	0.0	0.9	27.2	0.0	0.4	0.0	7.6	0.1	0.0	1.1	0.0	2.6	0.9	1.4	0.1	0.1	0.6	0.0	0.1	0.2	0.9	3.1	0.4	4.8	2.3	7.3	0.1	0.0	0.3	0.0	0.0	0.8	5.7	0.0	4.2	1.2	6.4	5.7	0.0	0.7	6.0	6.0	0.3	2.4	0.0	0.0	10.4	1.4	5.7	17.0	33.1	11.7	6.1	3.2	3.0	6.2	22.3	1.1
FOXP3	"AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID"	ENSG00000049768	"Forkhead box P3"	Q9BZS1	X	49250436-49264826	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.9;lymphoid tissue: 23.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 8.1;SiHa: 4.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	11	"T-reg: 25.9"	"Lineage enriched"	"Detected in single"	260	"T-cells: 25.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB026301, HPA045943"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB026301: , HPA045943: "	"unprognostic (2.46e-2)"	"prognostic favourable (1.91e-4)"	"unprognostic (4.95e-3)"	"prognostic favourable (7.02e-4)"	"unprognostic (2.55e-4)"	"prognostic favourable (4.90e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.73e-14)"	"unprognostic (5.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-1)"	0.4	0.4	1.4	20.2	1.3	1.4	0.6	2.2	1.2	0.7	0.8	0.5	1.0	0.6	1.1	7.2	2.6	0.3	3.3	0.4	1.3	1.0	1.1	4.7	1.9	23.3	0.9	0.4	0.6	0.4	0.1	1.2	0.4	0.4	0.9	0.6	0.6	4.0	0.6	0.4	2.5	4.0	0.4	0.7	4.7	1.8	2.7	0.4	23.3	0.8	1.8	20.6	4.9	0.6	0.0	0.0	0.0	0.0	0.0	25.9	0.4	0.3	0.5	0.5	1.2	0.2	0.0	1.5	0.3	0.0	0.4	0.1	0.4	0.3	0.9	0.4	0.4	0.4	0.9	0.0	0.3	3.0	0.4	0.4	0.6	0.1	0.7	0.7	0.9	0.3	0.5	0.7	0.8	0.0	1.5	0.8	0.1	8.1	0.3	0.6	1.2	0.8	0.6	0.3	0.6	0.4	0.5	0.7	0.4	4.8	0.5	3.0	1.8	0.7	0.1	0.1	1.6	0.8	0.2	0.8	1.6	1.0	0.5	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	25.9	0.4	1.4	1.3	2.2	1.2	1.3	1.0	0.9	0.4	0.4	0.4
CTLA4	"CD, CD152, CELIAC3, GSE, IDDM12"	ENSG00000163599	"Cytotoxic T-lymphocyte associated protein 4"	P16410	2	203867786-203873960	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.8;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.8;U-266/70: 5.8;U-266/84: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	6	"T-reg: 24.8"	"Lineage enriched"	"Detected in single"	248	"T-cells: 24.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"						"unprognostic (1.92e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.47e-3)"	"unprognostic (9.89e-6)"	"unprognostic (1.86e-1)"	"prognostic favourable (4.48e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.76e-1)"	"unprognostic (9.86e-10)"	"unprognostic (4.13e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-2)"	1.6	0.2	0.2	24.1	0.3	2.9	1.3	0.2	0.6	0.8	1.6	0.1	0.6	0.2	1.1	0.1	2.0	1.2	3.6	0.5	0.3	0.5	1.6	0.6	5.8	27.9	0.3	0.3	0.7	0.3	0.1	0.6	0.1	1.7	1.1	1.7	0.8	1.4	0.6	0.2	1.0	10.3	0.3	1.5	6.7	1.2	1.7	0.1	14.2	1.9	3.3	31.2	4.6	1.3	0.0	0.0	0.0	0.0	0.0	24.8	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.2	0.0	0.5	0.0	0.3	0.0	5.8	16.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	4.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	24.8	0.4	0.2	0.3	0.2	0.6	0.3	0.5	0.3	0.3	1.7	0.1
ELOVL4	"CT118, SCA34, STGD2, STGD3"	ENSG00000118402	"ELOVL fatty acid elongase 4"	Q9GZR5	6	79914812-79947580	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 92.6;skin 1: 41.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 21.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 19.1"	"Lineage enriched"	"Detected in single"	191	"T-cells: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.67e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.27e-4)"	1.2	2.6	6.0	1.6	8.8	0.6	4.7	16.0	15.5	2.2	1.4	2.3	0.2	1.1	2.8	1.6	11.0	0.9	2.2	0.9	8.4	10.4	1.9	0.6	0.7	0.9	6.3	4.8	2.3	1.0	10.7	7.6	2.2	19.3	4.7	1.6	15.5	3.0	2.3	0.7	41.9	1.3	3.2	3.5	1.0	1.0	5.8	2.3	92.6	2.0	4.4	2.2	1.8	2.6	0.0	0.0	0.0	0.0	0.0	19.1	0.6	0.0	0.6	7.5	8.3	6.3	6.1	1.1	3.8	4.2	3.3	7.2	1.0	0.0	0.0	0.7	5.2	0.7	9.7	5.4	2.4	0.0	12.6	0.3	1.6	0.0	5.8	2.9	1.2	4.9	2.0	3.3	3.4	5.3	0.0	0.0	6.9	1.3	21.5	0.0	7.2	3.9	0.0	10.8	0.0	0.1	0.0	9.9	2.9	4.1	6.6	1.1	2.6	0.2	0.5	1.5	2.9	2.2	2.9	5.0	10.0	0.0	3.5	0.0	2.2	0.0	0.0	0.0	1.8	0.0	19.1	0.0	2.6	3.1	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.2	0.6	6.0	8.8	16.0	13.5	8.4	10.4	6.3	4.8	19.3	2.3
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512538-83525704	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.1;ovary: 16.3"	"Group enriched"	"Detected in some"	4	"CACO-2: 42.1;RPTEC TERT1: 12.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	9	"MAIT T-cell: 17.1"	"Lineage enriched"	"Detected in single"	172	"T-cells: 17.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.2;cerebellum: 7.0;cerebral cortex: 7.5;hippocampal formation: 6.8;olfactory region: 5.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"					"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	2.0	3.8	7.7	1.3	11.3	0.0	0.6	0.2	9.3	4.8	0.4	2.5	0.3	0.5	2.2	2.1	0.6	2.2	6.2	5.6	4.8	1.1	4.9	0.7	2.0	3.0	1.1	5.4	16.3	0.6	0.9	1.5	5.2	2.7	2.7	0.6	11.1	0.4	0.7	0.4	0.5	0.4	2.2	1.4	1.1	0.6	4.6	1.3	0.0	0.7	0.4	0.2	2.0	0.9	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1	5.1	0.5	1.0	42.1	0.0	0.0	0.0	0.2	0.0	6.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	4.1	0.0	0.0	0.0	12.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	17.1	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.7	11.3	0.2	7.1	4.8	1.1	1.1	5.4	2.7	1.3
EDAR	"DL, ED1R, ED3, ED5, EDA1R, EDA3, Edar"	ENSG00000135960	"Ectodysplasin A receptor"	Q9UNE0	2	108894471-108989372	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.2;esophagus: 9.2;lymphoid tissue: 11.3"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.5;HaCaT: 14.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"naive CD4 T-cell: 10.2;naive CD8 T-cell: 4.8"	"Lineage enriched"	"Detected in single"	102	"T-cells: 10.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042292	Approved									"HPA042292: AB_10794648"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.83e-7)"	"unprognostic (9.21e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.03e-3)"	0.3	0.2	0.3	1.9	0.4	0.5	1.8	0.4	0.3	2.8	2.9	0.1	0.0	2.2	1.1	2.6	9.2	0.4	6.8	0.5	0.3	0.4	1.9	1.9	2.4	6.6	0.3	0.0	0.3	0.5	0.0	0.2	0.2	0.3	1.6	4.5	0.1	3.2	0.1	0.3	3.5	2.5	1.3	1.2	0.5	1.8	0.6	0.2	3.2	0.3	1.7	11.3	4.6	3.5	0.0	0.0	0.0	0.0	0.0	10.2	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	6.5	0.0	0.5	0.0	14.0	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	10.2	4.8	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.4	0.4	0.3	0.3	0.4	0.3	0.0	0.3	0.2
PDCD1	"CD279, hSLE1, PD-1, PD1, SLEB2"	ENSG00000188389	"Programmed cell death 1"	Q15116	2	241849881-241858908	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.6;lymphoid tissue: 21.5"	"Group enriched"	"Detected in some"	14	"MOLT-4: 9.3;RPMI-8226: 9.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 4.1;MAIT T-cell: 3.9;memory CD4 T-cell: 6.8;memory CD8 T-cell: 11.6;T-reg: 3.5"	"Lineage enriched"	"Detected in single"	93	"T-cells: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035981, CAB038418, CAB076386"	Enhanced									"CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664"	"unprognostic (2.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (7.78e-2)"	"prognostic favourable (9.44e-5)"	"unprognostic (7.18e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.82e-3)"	"unprognostic (3.75e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.94e-1)"	"prognostic unfavourable (3.48e-7)"	"unprognostic (1.20e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.35e-2)"	"unprognostic (5.06e-3)"	1.4	0.4	0.0	21.5	0.7	3.0	0.5	0.1	0.3	1.2	1.9	0.0	0.0	0.4	0.5	1.6	2.0	0.8	1.7	9.2	0.2	0.5	1.3	0.5	5.6	16.6	0.1	0.3	0.7	1.0	0.2	1.9	0.3	0.4	1.3	0.2	1.2	3.0	0.5	0.2	0.2	4.9	0.4	0.3	9.5	1.9	0.4	0.2	16.6	1.9	3.0	20.1	1.3	0.8	0.1	0.0	0.0	0.0	0.0	11.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	9.3	0.0	0.0	0.0	0.0	0.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	3.9	0.1	6.8	11.6	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	3.5	1.5	0.0	0.7	0.1	0.1	0.2	0.5	0.1	0.3	0.4	0.2
C15orf53	FLJ35695	ENSG00000175779	"Chromosome 15 open reading frame 53"	Q8NAA6	15	38628005-39180499	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 8.0;gallbladder: 6.3"	"Group enriched"	"Detected in some"	9	"HEL: 4.6;HMC-1: 3.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.2"	"Cell type enriched"	"Detected in single"	10	"T-reg: 8.0"	"Lineage enriched"	"Detected in single"	81	"T-cells: 8.0"									HPA041914	Uncertain									"HPA041914: AB_10794640"	"unprognostic (9.94e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.30e-1)"			"unprognostic (5.38e-5)"	"unprognostic (1.02e-1)"	"unprognostic (8.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (3.58e-1)"		"unprognostic (4.30e-5)"	"unprognostic (2.59e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.49e-3)"	0.2	0.1	0.1	2.8	0.1	0.2	0.2	0.4	0.1	0.3	1.9	0.0	0.0	0.3	0.3	1.8	0.7	0.3	6.3	0.2	0.1	0.1	0.3	0.2	2.3	0.5	0.3	0.0	1.3	0.1	0.0	0.1	0.0	1.2	0.2	0.3	0.0	1.3	0.1	0.2	0.6	1.0	0.8	0.7	1.7	0.5	0.2	0.0	0.1	0.2	2.4	3.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.3	0.0	1.2	0.0
LAG3	CD223	ENSG00000089692	"Lymphocyte activating 3"	P18627	12	6772512-6778455	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.1;ovary: 28.4"	"Cell line enriched"	"Detected in single"	144	"HDLM-2: 55.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.7"	"Cell type enhanced"	"Detected in many"		"gdTCR: 11.3;MAIT T-cell: 9.2;memory CD8 T-cell: 10.0"	"Lineage enriched"	"Detected in single"	56	"T-cells: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002301, HPA013967"	Enhanced				"Secreted - unknown location"					"CAB002301: AB_564101, HPA013967: AB_1846277"	"unprognostic (9.39e-2)"	"prognostic favourable (3.89e-4)"	"unprognostic (8.88e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.74e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavourable (4.62e-11)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	"unprognostic (8.19e-3)"	1.7	0.4	0.3	33.2	0.3	1.0	1.0	0.8	0.7	7.7	4.4	0.5	2.7	2.9	6.4	3.3	2.4	3.8	3.0	2.2	0.3	0.4	1.2	5.9	3.8	12.4	0.4	0.0	28.4	0.4	0.1	1.0	1.3	2.7	2.8	1.8	1.1	2.0	6.8	0.8	0.6	9.6	1.7	0.9	58.1	2.0	6.1	0.1	4.1	1.0	1.3	23.5	2.6	3.6	0.0	0.2	0.0	0.0	0.0	11.3	0.8	0.0	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	55.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	9.2	0.0	2.2	10.0	0.0	0.0	0.6	4.0	0.0	0.0	0.0	0.2	1.7	0.8	0.3	0.3	0.8	0.7	0.3	0.4	0.4	0.0	2.7	0.1
CD6	Tp120	ENSG00000013725	"CD6 molecule"	P30203	11	60971680-61020377	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.0;lymphoid tissue: 58.1"	"Cell line enriched"	"Detected in some"	18	"MOLT-4: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	34	"gdTCR: 12.4;MAIT T-cell: 11.1;memory CD4 T-cell: 23.0;memory CD8 T-cell: 21.4;naive CD4 T-cell: 15.5;naive CD8 T-cell: 11.1;T-reg: 10.1"	"Lineage enriched"	"Detected in single"	52	"T-cells: 23.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002489, CAB016252"	Enhanced				"Secreted to blood"	110000	110000			"CAB002489: AB_563605, CAB016252: AB_631163"	"prognostic favourable (1.95e-4)"	"prognostic favourable (1.57e-5)"	"unprognostic (4.47e-2)"	"prognostic favourable (2.41e-4)"	"unprognostic (2.06e-2)"	"prognostic favourable (5.10e-6)"	"unprognostic (8.45e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.87e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.35e-1)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.96e-2)"	1.5	0.5	0.8	26.4	0.4	5.5	0.9	0.5	1.4	1.3	3.3	0.6	0.8	2.2	1.4	1.5	1.9	1.3	5.0	1.3	0.7	1.8	1.6	1.1	6.9	25.6	1.7	0.5	0.7	0.8	0.0	0.6	0.6	0.4	1.2	1.6	1.2	7.0	0.3	0.3	0.9	13.0	0.7	0.9	18.4	3.4	0.9	0.1	58.1	1.6	1.9	42.0	3.7	1.3	0.4	0.1	0.3	0.0	0.0	23.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.6	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.4	0.0	11.1	0.4	23.0	21.4	0.1	0.4	15.5	11.1	0.3	0.0	0.0	0.0	10.1	5.1	0.8	0.4	0.5	1.4	0.7	1.8	1.7	0.5	0.4	0.1
NTN4		ENSG00000074527	"Netrin 4"	Q9HB63	12	95657807-95791152	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 76.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 92.6;hTERT-HME1: 38.3;PC-3: 35.0;TIME: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"MAIT T-cell: 4.9"	"Lineage enriched"	"Detected in single"	49	"T-cells: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049832	Approved				"Secreted to extracellular matrix"					"HPA049832: AB_2680905"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (9.50e-4)"	"unprognostic (2.85e-1)"	"prognostic favourable (8.12e-9)"	"unprognostic (3.52e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.93e-1)"	"prognostic favourable (6.67e-5)"	11.1	8.5	4.0	4.4	6.3	0.0	22.8	1.2	9.0	9.9	8.9	2.5	7.3	3.4	8.2	11.9	10.7	10.7	13.0	27.2	3.9	2.4	35.8	13.6	21.7	0.7	4.1	6.1	28.5	18.2	6.6	4.5	7.7	2.8	24.1	5.4	8.4	14.7	19.6	7.2	3.8	8.7	7.2	2.2	76.9	14.5	6.5	2.2	1.5	6.7	9.7	4.2	14.1	11.9	0.0	0.0	0.0	0.0	0.0	4.9	0.0	4.7	13.0	0.3	0.0	5.3	8.5	0.5	9.1	92.6	12.3	14.8	10.2	9.0	0.0	0.6	19.1	7.6	0.1	2.7	6.3	0.0	0.8	0.4	2.4	1.9	0.3	0.0	0.0	0.2	7.9	14.2	38.3	24.2	0.0	0.0	4.6	3.5	0.0	0.0	0.2	35.0	0.0	0.1	0.0	12.0	24.4	0.0	0.1	11.0	14.1	0.2	4.1	0.0	52.6	4.8	1.8	18.8	0.9	0.0	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	6.3	1.2	9.0	3.9	2.4	4.1	6.1	2.8	2.2
RORC	"NR1F3, RORG, RZRG, TOR"	ENSG00000143365	"RAR related orphan receptor C"	P51449	1	151806071-151831872	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.8;skeletal muscle: 63.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.1;Karpas-707: 11.0;MOLT-4: 5.6;RPMI-8226: 5.8;SK-BR-3: 5.0;T-47d: 8.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 7.0;pons and medulla: 2.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 28.3"	"Lineage enriched"	"Detected in single"	44	"T-cells: 28.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA065620			Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA065620: AB_2685521"	"unprognostic (6.51e-2)"	"unprognostic (7.78e-2)"	"prognostic favourable (1.83e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-4)"	"unprognostic (6.29e-5)"	"unprognostic (1.13e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (2.94e-5)"	"unprognostic (2.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-2)"	1.3	1.6	0.4	3.4	0.9	0.0	3.3	7.0	0.3	2.7	10.0	0.7	19.8	4.2	1.2	6.7	3.4	8.7	3.5	4.8	0.4	0.5	13.3	30.8	8.7	0.7	0.9	0.3	1.3	30.3	8.5	9.4	0.2	2.4	7.0	4.0	2.8	27.8	33.4	63.8	9.8	10.3	0.8	0.3	0.7	7.7	6.4	1.1	69.8	15.6	11.1	4.0	2.4	1.7	0.0	0.1	0.0	0.0	0.6	28.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	2.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.1	5.6	0.0	0.0	0.0	0.0	0.0	5.8	0.3	0.0	0.0	0.2	0.1	5.0	0.0	8.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.9	0.0	28.3	0.0	4.4	4.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	3.0	0.6	0.4	0.9	7.0	0.3	0.4	0.5	0.9	0.3	2.4	1.1
COLQ	EAD	ENSG00000206561	"Collagen like tail subunit of asymmetric acetylcholinesterase"	Q9Y215	3	15450133-15521751	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 31.8;lymphoid tissue: 19.6"	"Group enriched"	"Detected in some"	5	"BEWO: 16.9;HDLM-2: 5.5;U-937: 8.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 11.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 31.8"	"Lineage enriched"	"Detected in single"	35	"T-cells: 31.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045876			Approved	"Plasma membrane,Cell Junctions"	"Secreted to blood"			"Plasma membrane"	"Cell Junctions"	"HPA045876: AB_2679479"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.68e-1)"	"unprognostic (7.00e-5)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-4)"	2.7	0.7	0.9	0.7	1.1	1.3	0.9	11.4	2.1	2.4	2.3	0.4	0.2	0.8	3.2	2.7	1.3	8.8	1.8	15.9	1.5	1.2	0.5	0.9	2.1	19.6	0.9	1.1	2.3	0.6	10.0	1.1	0.5	2.1	2.0	0.5	2.0	1.1	1.4	14.3	0.9	1.4	1.1	1.5	3.8	1.5	2.0	0.4	3.8	1.0	0.6	3.3	1.3	1.4	0.0	0.2	0.0	0.4	0.9	31.8	1.7	0.1	0.5	2.0	1.1	1.4	1.0	16.9	0.3	0.5	0.4	0.6	0.0	0.3	0.1	0.7	0.2	0.2	0.3	0.4	0.5	5.5	1.2	0.6	0.7	0.1	0.2	0.4	1.1	0.8	0.4	0.8	0.3	0.3	0.0	0.5	0.8	0.3	0.6	1.8	0.2	0.6	0.8	0.2	0.4	0.4	0.4	0.6	1.7	0.2	0.1	0.4	1.2	0.8	0.1	0.1	1.0	1.8	0.6	1.6	1.5	0.1	0.1	8.5	0.1	0.0	0.4	0.0	5.5	0.0	31.8	0.0	2.7	3.9	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.2	0.1	1.7	0.9	1.1	11.4	2.1	1.5	1.2	0.9	1.1	2.1	0.4
IL23R	IL-23R	ENSG00000162594	"Interleukin 23 receptor"	Q5VWK5	1	67138907-67259979	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 18.1;lymphoid tissue: 11.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.6;HMC-1: 10.5;K-562: 3.9;U-2197: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"MAIT T-cell: 18.1"	"Lineage enriched"	"Detected in single"	35	"T-cells: 18.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056427	Uncertain									"HPA056427: AB_2683129"	"unprognostic (4.01e-3)"	"unprognostic (8.04e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.73e-2)"	"unprognostic (6.41e-3)"	0.2	4.8	0.2	11.0	0.3	0.0	0.2	0.2	0.2	0.2	2.4	0.2	0.0	0.9	0.3	1.0	0.3	0.2	0.6	0.2	0.2	0.2	0.3	0.5	0.5	4.8	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.2	2.6	0.6	2.3	0.0	0.2	0.2	2.7	0.0	0.2	3.3	1.3	4.1	0.0	1.2	0.2	1.4	7.6	0.9	0.3	0.0	0.0	0.0	0.0	0.5	18.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	2.6	10.5	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	15.8	0.0	0.3	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	18.1	0.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
CAMK4	CaMK-GR	ENSG00000152495	"Calcium/calmodulin dependent protein kinase IV"	Q16566	5	111223653-111494886	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.9;lymphoid tissue: 71.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.2;MOLT-4: 12.6;SH-SY5Y: 16.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 14.1;memory CD4 T-cell: 10.3;memory CD8 T-cell: 7.8;naive CD4 T-cell: 19.8;naive CD8 T-cell: 10.9;T-reg: 11.3"	"Lineage enriched"	"Detected in single"	26	"T-cells: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	"unprognostic (2.99e-5)"	"unprognostic (7.19e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.66e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-5)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	1.1	6.5	9.5	6.4	34.2	4.6	1.0	48.9	16.5	1.8	2.3	1.0	0.0	2.4	1.3	0.8	1.4	0.9	2.7	0.9	5.9	3.2	1.4	2.5	1.9	12.0	2.3	6.8	1.4	0.9	0.3	1.3	0.6	3.4	5.8	2.5	0.1	1.7	2.6	0.8	0.9	3.8	1.5	2.0	4.2	2.6	13.8	6.6	71.7	1.0	0.0	8.1	2.8	1.1	0.7	0.0	0.4	0.0	0.6	19.8	3.4	0.0	0.0	1.4	1.0	0.3	1.1	0.0	0.3	3.2	3.8	3.7	0.0	0.0	0.0	2.0	0.1	0.1	3.1	0.3	2.8	41.2	2.6	0.6	1.3	0.0	0.1	0.2	0.1	0.1	0.0	8.0	0.8	0.6	0.0	1.5	0.2	0.0	12.6	0.0	1.9	0.1	1.9	2.4	0.1	1.4	0.0	9.1	16.1	0.5	0.0	2.7	0.0	0.2	0.0	7.8	4.6	0.0	6.9	1.3	0.1	0.0	3.8	0.0	3.0	0.0	0.0	0.0	2.8	0.0	14.1	0.7	10.3	7.8	0.0	0.2	19.8	10.9	0.4	0.6	0.0	0.0	11.3	3.4	9.5	34.2	48.9	15.1	5.9	3.2	2.3	6.8	3.4	6.6
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496632-93529092	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.9;testis: 19.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023430	Approved		Supported	"Plasma membrane,Midbody,Centriolar satellite"				"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavourable (3.20e-9)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (0.00e+0)"	"prognostic favourable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	3.2	1.4	0.5	12.1	0.4	3.1	3.6	0.3	0.6	2.0	5.2	0.3	0.2	4.6	0.8	1.5	11.6	0.6	2.5	0.7	0.4	0.5	1.5	0.7	4.4	10.1	0.6	0.2	0.8	0.6	0.0	0.7	3.8	0.5	0.8	6.5	0.4	2.3	0.2	0.7	3.0	5.2	3.5	1.1	4.8	3.2	19.3	0.3	52.9	0.7	10.8	11.0	2.7	3.3	0.1	0.1	0.0	0.0	0.0	4.4	0.0	51.0	20.4	13.6	17.2	1.5	3.1	7.6	28.1	19.9	26.7	27.7	21.6	27.5	13.6	12.4	18.2	29.2	16.4	13.8	32.1	41.0	8.5	5.1	12.6	7.3	0.1	8.8	11.9	0.7	1.0	28.4	34.7	24.6	4.6	25.9	30.1	11.8	23.2	13.4	5.3	14.9	10.1	22.2	7.5	12.0	6.3	5.6	7.9	21.6	6.7	17.0	17.5	9.0	15.3	16.9	23.7	23.2	46.1	11.6	15.7	16.7	13.2	33.4	15.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.5	0.4	0.3	0.6	0.4	0.5	0.6	0.2	0.5	0.3
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA064882: AB_2685381, HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	1.0	0.4	0.4	7.2	0.2	11.5	0.3	0.2	0.4	1.6	3.6	0.2	0.2	3.3	1.2	1.4	8.2	0.9	2.0	3.4	0.2	0.2	0.4	0.5	0.8	6.1	0.2	0.2	0.7	0.3	0.0	0.2	4.0	0.2	0.6	4.8	1.2	1.8	0.9	11.5	2.6	4.6	0.7	0.2	2.4	5.1	4.7	0.2	30.3	0.3	8.0	12.5	3.4	2.1	0.0	0.1	0.0	0.0	0.0	2.9	0.4	14.2	4.3	4.4	6.1	0.2	0.6	18.9	7.9	2.2	9.3	10.1	14.7	4.7	14.1	3.3	2.5	12.6	10.8	1.0	8.5	9.5	8.7	4.9	2.4	4.0	0.0	7.5	11.9	0.2	0.0	1.9	0.6	13.1	10.3	13.7	3.7	6.9	14.6	9.3	4.1	6.0	15.9	8.3	9.6	4.0	9.7	3.8	4.3	3.5	7.0	0.8	4.8	8.0	2.5	4.5	5.6	11.0	7.1	4.7	9.5	17.9	5.7	14.7	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.4	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2
BDKRB1	"B1BKR, BKR1, bradyb1"	ENSG00000100739	"Bradykinin receptor B1"	P46663	14	96255824-96268967	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 16.1;lymphoid tissue: 17.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 11.6;HHSteC: 11.9;hTEC/SVTERT24-B: 11.1;U-2197: 12.3;U-87 MG: 40.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	"Cell type enriched"	"Detected in single"	19	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.8"	"Low region specificity"	"Detected in single"							HPA002935	Approved									"HPA002935: AB_1078274"	"unprognostic (6.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (9.96e-6)"	"unprognostic (2.33e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.66e-2)"	7.3	0.0	0.2	17.1	0.2	0.0	0.8	2.1	0.6	5.4	3.7	0.2	0.2	1.8	0.7	2.8	10.4	4.8	16.1	2.3	0.2	0.0	2.4	0.6	3.7	0.2	0.2	0.2	4.5	7.9	0.0	0.2	3.0	0.4	2.2	2.8	0.7	1.5	1.1	0.4	2.4	3.7	5.7	0.2	0.6	3.3	2.3	0.2	0.2	0.8	4.6	2.0	13.7	5.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.6	0.0	0.4	1.1	3.9	0.0	1.0	11.6	1.2	0.2	0.0	0.2	0.0	0.0	6.7	1.1	0.0	0.1	1.9	0.1	0.0	0.0	1.1	0.0	11.9	0.0	0.0	0.4	0.9	11.1	0.2	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.1	0.0	0.4	0.0	3.2	1.1	0.0	0.0	0.0	0.0	4.4	0.2	12.3	0.6	2.1	4.0	0.0	40.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.2	2.1	0.6	0.2	0.0	0.2	0.2	0.4	0.2
ATP12A	"#945, 2, ATP1AL1, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680411-24712493	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 12.3;lymphoid tissue: 38.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;HEL: 3.2;NTERA-2: 1.0;U-266/84: 2.8;U-937: 1.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	5	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039526	Approved									"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.2	1.3	0.4	0.1	0.0	0.0	0.0	0.2	0.2	12.3	0.1	0.0	0.1	0.3	0.2	8.8	0.1	6.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	5.8	0.4	0.3	2.2	0.0	0.4	0.0	0.1	9.8	0.1	0.0	0.1	0.1	0.1	1.0	0.0	1.2	0.2	2.9	38.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.3	0.0	0.5	1.2	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.8	0.1	0.0	1.6	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.2	1.3	0.3	0.2	0.1	0.0	0.4	0.0
GPR171	H963	ENSG00000174946	"G protein-coupled receptor 171"	O14626	3	151197832-151203201	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.2;intestine: 19.5;lymphoid tissue: 33.0"	"Cell line enriched"	"Detected in single"	26	"U-266/70: 24.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 45.2"	"Lineage enriched"	"Detected in many"	18	"T-cells: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062429	Approved									"HPA062429: AB_2684760"	"unprognostic (6.82e-6)"	"unprognostic (4.90e-3)"	"unprognostic (7.10e-2)"	"unprognostic (6.85e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.04e-3)"	"unprognostic (4.19e-4)"	"unprognostic (6.09e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"	4.1	0.9	0.4	15.1	0.4	0.4	1.6	0.3	0.3	4.0	6.8	0.3	0.6	3.5	1.4	1.6	2.7	3.9	4.6	1.3	0.4	0.4	4.3	2.7	10.7	33.0	0.7	0.5	1.9	1.0	0.0	0.7	0.8	1.5	2.2	3.8	1.7	2.4	1.2	1.0	1.1	19.5	1.1	2.7	20.7	4.0	1.0	0.5	19.9	2.2	1.8	8.5	7.0	2.4	0.1	0.8	1.0	0.1	2.5	45.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	11.6	0.0	45.2	0.0	16.2	21.5	0.8	0.1	9.9	8.4	0.3	2.5	0.1	0.7	8.0	3.4	0.4	0.4	0.3	0.3	0.4	0.4	0.7	0.5	1.5	0.5
OR2T34		ENSG00000183310	"Olfactory receptor family 2 subfamily T member 34"	Q8NGX1	1	248573801-248574757	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"blood: 1.4"	"Cell line enriched"	"Detected in single"	15	"Karpas-707: 1.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	15	"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.4"																																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.4		0.3	0.0		0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0			0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"B cell CLL/lymphoma 11B"	Q9C0K0	14	99169287-99271524	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.7;lymphoid tissue: 25.4;skin 1: 17.6"	"Cell line enriched"	"Detected in some"	6	"MOLT-4: 32.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 13.7"	"Group enriched"	"Detected in many"	8	"gdTCR: 3.3;MAIT T-cell: 3.0;memory CD4 T-cell: 4.5;memory CD8 T-cell: 3.7;naive CD4 T-cell: 7.4;naive CD8 T-cell: 4.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favourable (7.48e-4)"	0.3	0.4	4.4	6.6	13.7	5.2	1.3	0.3	3.8	0.8	1.3	0.1	0.0	2.3	1.9	0.8	3.9	0.3	3.0	0.8	4.8	1.0	0.3	0.5	1.1	10.8	0.8	2.6	0.2	0.1	0.0	0.1	0.0	0.6	0.6	1.7	0.3	5.0	0.7	0.1	17.6	3.0	0.2	0.7	4.9	2.1	0.4	1.6	25.4	0.9	1.5	8.8	2.0	2.3	0.0	0.0	0.1	0.0	0.5	7.4	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	1.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	3.0	0.0	1.8	32.6	0.5	0.3	0.0	5.1	0.0	0.0	0.0	1.8	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	2.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.1	3.3	0.0	3.0	0.0	4.5	3.7	0.0	0.0	7.4	4.9	0.0	0.5	0.0	0.0	3.0	1.1	4.4	13.7	0.3	3.8	4.8	1.0	0.8	2.6	0.6	1.6
FHIT	"AP3Aase, FRA3B"	ENSG00000189283	"Fragile histidine triad"	P49789	3	59749310-61251459	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 11.9;U-266/70: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"naive CD4 T-cell: 38.3"	"Lineage enriched"	"Detected in all"	14	"T-cells: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002684, HPA018840, HPA018909"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane"				"Nucleoli fibrillar center, Plasma membrane"		"CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537"	"unprognostic (2.36e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.77e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.80e-2)"	6.4	24.0	13.7	8.0	17.5	9.0	12.1	4.7	13.3	7.9	8.0	21.0	12.4	8.2	6.2	9.5	5.1	9.2	13.0	14.9	15.3	13.8	30.9	10.7	5.2	9.3	19.5	9.3	8.9	11.8	16.3	15.2	4.1	14.4	5.8	7.8	14.0	11.4	9.9	11.6	7.0	7.6	9.1	17.1	6.0	8.1	10.5	18.2	3.7	15.6	5.7	6.9	7.3	6.1	1.6	2.4	1.8	1.8	2.6	38.3	4.7	0.0	0.0	1.0	0.0	0.6	0.0	1.6	0.1	0.1	0.0	0.0	1.8	3.0	2.6	0.5	0.1	0.0	10.0	2.1	0.0	1.4	3.4	2.2	1.3	4.1	2.6	5.6	0.1	6.8	4.1	0.1	5.1	0.0	1.6	8.3	0.1	2.5	10.1	4.5	0.8	0.6	7.5	0.0	11.9	11.2	1.3	2.1	2.8	1.0	6.9	6.5	0.4	0.1	0.0	1.2	0.4	0.1	1.5	24.4	7.4	0.0	2.7	0.0	1.4	1.8	1.8	0.2	0.9	1.2	0.5	1.6	6.9	0.7	2.2	1.4	38.3	6.7	0.3	2.6	0.4	2.4	7.4	4.7	13.7	17.5	4.7	13.3	15.3	13.8	19.5	9.3	14.4	18.2
OR13C8		ENSG00000186943	"Olfactory receptor family 13 subfamily C member 8"	Q8NGS7	9	104569168-104570130	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"blood: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	13	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0			0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0										
OR4A47		ENSG00000237388	"Olfactory receptor family 4 subfamily A member 47"	Q6IF82	11	48488717-48489780	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"blood: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	13	"memory CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Not detected"	"Not detected"							HPA059763	Uncertain									"HPA059763: AB_2684122"																		0.0	0.0	0.2	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.6	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0			0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NKX2-3	"CSX3, NKX2.3, NKX2C, NKX4-3"	ENSG00000119919	"NK2 homeobox 3"	Q8TAU0	10	99532933-99536524	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;NB-4: 4.7;REH: 6.0;THP-1: 1.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.3"	HPA047561	Uncertain		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA047561: AB_2680088"		"unprognostic (5.70e-2)"	"unprognostic (2.95e-1)"			"unprognostic (2.70e-4)"	"unprognostic (6.34e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	0.8	0.0	0.1	17.2	0.1	0.0	0.1	0.1	0.1	0.3	21.6	0.1	0.1	10.4	0.2	0.1	0.5	0.0	12.5	0.1	0.1	0.0	0.1	0.2	0.1	1.1	0.1	0.1	0.1	6.4	0.0	0.1	0.1	0.1	0.1	4.6	0.1	9.0	0.5	0.1	0.0	19.1	3.1	0.1	36.8	1.8	0.1	0.1	0.2	1.0	0.7	3.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	6.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PRDM13		ENSG00000112238	"PR/SET domain 13"	Q9H4Q3	6	99606730-99615578	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"blood: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070592	Uncertain									"HPA070592: AB_2686283"		"unprognostic (4.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"		"unprognostic (3.16e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.93e-1)"				"unprognostic (1.86e-2)"	"unprognostic (7.54e-2)"		"unprognostic (1.29e-1)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TNIP3	"ABIN-3, FLJ21162, LIND"	ENSG00000050730	"TNFAIP3 interacting protein 3"	Q96KP6	4	121131408-121227466	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 9.2;lung: 8.5;lymphoid tissue: 15.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.6;hTEC/SVTERT24-B: 6.4;U-138 MG: 24.9;U-266/70: 7.0;U-266/84: 6.9;U-87 MG: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 9.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 9.2"					"Low region specificity"	"Detected in all"			HPA043063	Uncertain									"HPA043063: AB_10793989"	"unprognostic (2.89e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.23e-3)"	"unprognostic (8.75e-5)"	"unprognostic (9.62e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.84e-7)"	"unprognostic (3.35e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.78e-2)"	2.2	0.3	1.0	9.8	0.2	1.3	0.3	0.3	0.7	2.0	1.3	0.2	0.2	0.6	0.2	0.2	1.8	0.4	1.5	0.4	0.4	0.6	0.3	0.7	8.5	3.5	0.7	0.2	0.2	0.2	0.0	0.2	0.2	0.5	0.9	0.4	0.2	0.8	0.2	0.4	0.3	1.2	0.5	0.3	2.8	0.8	1.4	0.2	15.4	0.4	3.6	6.3	1.3	0.4	0.2	0.1	0.7	0.2	0.1	9.2	0.8	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.9	0.1	0.1	0.1	2.1	0.0	0.0	0.5	0.8	5.6	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	6.4	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	24.9	0.5	2.0	0.1	7.0	6.9	0.2	5.1	0.2	0.8	0.7	0.2	0.0	4.0	0.0	2.7	0.1	1.8	9.2	0.0	0.2	0.8	4.4	0.6	0.1	0.2	0.1	1.1	0.8	1.0	0.2	0.3	0.7	0.4	0.6	0.7	0.2	0.5	0.2
CCL20	"CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38"	ENSG00000115009	"C-C motif chemokine ligand 20"	P78556	2	227805739-227817564	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.5;lung: 36.8;lymphoid tissue: 50.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.5;NB-4: 17.7;RT4: 10.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (2.40e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.87e-2)"	"unprognostic (7.06e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (1.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-1)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.19e-8)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.82e-1)"	5.6	0.1	0.4	23.3	0.9	1.5	0.4	0.3	0.4	7.1	5.5	0.3	0.3	4.4	3.9	1.5	11.8	2.0	48.5	1.5	0.4	0.2	7.1	17.2	36.8	16.3	0.4	0.3	1.5	1.9	0.0	0.3	0.9	1.3	2.0	7.8	0.4	4.0	0.3	0.5	4.3	18.2	1.0	1.3	0.5	2.8	1.6	0.4	1.8	0.5	18.3	50.9	19.6	2.5	0.3	0.6	0.0	0.3	0.0	6.6	0.3	0.3	1.0	0.5	0.6	2.3	4.7	0.6	0.3	1.4	0.1	0.5	2.7	0.4	0.8	3.2	0.0	0.5	0.1	6.1	1.0	0.6	1.0	0.1	2.0	24.5	1.8	3.4	0.3	7.3	1.3	1.4	1.7	0.0	0.2	3.8	0.4	0.2	0.2	17.7	1.2	0.6	0.5	6.3	0.7	0.1	10.8	0.4	0.3	0.2	1.0	0.6	0.9	3.5	1.8	2.3	3.1	5.2	0.5	0.7	2.0	1.4	3.6	2.4	4.8	0.0	0.3	0.0	0.1	0.1	6.6	0.2	2.7	1.4	0.3	0.3	0.4	0.3	0.0	0.0	0.2	0.6	1.0	0.3	0.4	0.9	0.3	0.4	0.4	0.2	0.4	0.3	1.3	0.4
FGFBP2	KSP37	ENSG00000137441	"Fibroblast growth factor binding protein 2"	Q9BYJ0	4	15960243-15969309	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 79.8"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 10.9;T-47d: 5.4;WM-115: 2.2"	"Group enriched"	"Detected in many"	9	"glioma: 4.8;head and neck cancer: 13.1;lung cancer: 16.7;melanoma: 16.9"	"Region enriched"	"Detected in many"	6	"midbrain: 16.0"	"Cell type enhanced"	"Detected in many"		"gdTCR: 79.8"	"Lineage enriched"	"Detected in many"	10	"T-cells: 79.8"														"Secreted to blood"	6900000	6900000				"unprognostic (3.51e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.49e-2)"	21.0	1.4	0.3	0.4	1.0	33.4	19.4	0.0	0.9	1.1	7.1	0.2	0.9	0.2	0.6	6.0	3.4	0.7	0.8	16.1	0.4	0.2	0.5	0.8	6.7	1.9	16.0	1.0	0.9	0.2	0.1	0.2	0.8	2.8	3.1	0.8	30.7	5.7	0.9	6.7	14.4	1.8	5.3	5.0	10.4	1.2	11.3	0.0	5.8	0.7	3.8	1.9	1.5	3.7	0.1	0.2	1.2	0.2	8.3	79.8	39.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	10.9	5.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	2.2	0.4	0.1	0.3	79.8	0.1	0.7	0.1	19.7	47.0	0.1	0.0	7.6	47.5	1.2	8.3	0.2	0.2	0.1	39.3	0.3	1.0	0.0	0.9	0.4	0.2	16.0	1.0	2.8	0.0
IL26	"AK155, IL-26"	ENSG00000111536	"Interleukin 26"	Q9NPH9	12	68201351-68225821	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.0;tongue: 5.4;urinary bladder: 4.4"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 2.2;memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;T-reg: 1.1"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.2"					"Low region specificity"	"Detected in all"								"Secreted to blood"							"unprognostic (2.71e-1)"	"unprognostic (8.87e-2)"			"unprognostic (3.26e-5)"		"unprognostic (7.10e-2)"	"unprognostic (5.90e-2)"		"unprognostic (2.96e-1)"		"unprognostic (3.69e-5)"	"unprognostic (3.80e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.79e-2)"	0.1	0.0	0.5	6.0	0.2	0.0	0.0	0.7	0.1	0.1	1.0	0.0	0.0	0.2	0.0	0.0	1.4	0.1	0.5	0.3	1.0	0.2	0.1	0.1	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	2.3	0.0	0.0	0.5	1.4	0.0	0.1	1.1	0.3	0.3	0.0	0.5	0.1	5.4	3.5	4.4	0.3	0.2	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	1.5	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.5	0.2	0.7	0.1	1.0	0.2	0.1	0.0	0.0	0.0
SSTR3		ENSG00000278195	"Somatostatin receptor 3"	P32745	22	37204238-37212322	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 11.1;lymphoid tissue: 29.6;testis: 11.3"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 21.8;SCLC-21H: 8.2"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.9"					"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.9;naive CD8 T-cell: 3.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022647	Approved									"CAB022647: "	"unprognostic (1.63e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.26e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.06e-2)"	0.1	0.8	2.8	1.9	1.9	0.9	0.1	2.7	11.1	0.0	0.5	0.2	0.0	2.6	1.9	0.2	0.1	0.1	0.1	0.0	5.6		0.1	0.0	0.1	3.5	0.0	7.9	5.8	3.9	0.0	6.4	0.0	7.9	0.2	0.6	0.0	0.6	0.1	0.0	0.0	1.0	2.2	4.3	1.2	0.5	11.3	0.1	29.6	0.0	0.0	2.0	0.3	0.0	0.3	0.1	0.1	0.0	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	8.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	3.9	3.0	0.1	0.0	0.0	0.1	0.3	0.8										
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6461151-6466195	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.7;NB-4: 7.8;RPMI-8226: 19.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	11	"cerebellum: 19.2"	"Cell type enhanced"	"Detected in many"		"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 9.5"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"			"Plasma membrane, Actin filaments, Focal adhesion sites"	Nucleoplasm	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favourable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavourable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	2.2	1.6	1.2	20.3	1.6	0.4	1.4	19.2	1.8	1.4	13.4	0.7	0.6	2.8	1.2	0.6	4.1	2.4	2.1	2.3	1.8	0.9	1.4	2.3	6.3	13.9	1.1	0.6	1.1	0.6	1.4	14.0	4.1	1.3	1.9	1.3	1.1	10.5	2.3	0.8	24.1	11.2	0.6	0.6	18.9	0.8	1.0	0.8	11.7	1.1	3.2	26.0	3.2	1.5	0.0	0.4	0.0	0.9	0.6	9.5	1.3	1.4	0.3	0.8	1.5	0.0	0.4	0.8	0.6	0.4	0.2	0.0	1.2	2.1	0.0	2.9	0.0	3.1	0.4	3.6	0.0	19.7	1.4	0.8	1.1	0.0	0.6	0.0	0.0	0.0	2.4	1.2	3.1	3.1	0.0	0.0	0.0	1.6	0.0	7.8	1.0	5.3	0.6	0.2	19.3	0.8	0.5	3.8	5.2	0.0	1.9	0.1	1.6	2.1	1.6	1.0	1.5	0.0	1.5	0.0	3.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.7	0.3	8.0	0.0	6.9	3.2	0.4	0.0	6.4	1.1	0.0	0.6	0.9	0.0	9.5	1.3	1.2	1.6	19.2	1.8	1.8	0.9	1.1	0.6	1.3	0.8
S1PR5	"Edg-8, EDG8"	ENSG00000180739	"Sphingosine-1-phosphate receptor 5"	Q9H228	19	10512742-10517931	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 62.0;brain: 37.8;skin 1: 25.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 21.5;HBEC3-KT: 8.3;RT4: 14.0;T-47d: 8.9;U-2 OS: 8.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 11.7;head and neck cancer: 8.0;lung cancer: 3.7;urothelial cancer: 6.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdTCR: 62.0;MAIT T-cell: 38.0;memory CD8 T-cell: 29.2;naive CD8 T-cell: 23.2"	"Lineage enriched"	"Detected in many"	8	"T-cells: 62.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029683	Enhanced									"HPA029683: AB_10603237"	"unprognostic (9.07e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.55e-4)"	"unprognostic (4.21e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (6.71e-7)"	"unprognostic (2.46e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.52e-1)"	1.4	1.0	10.0	1.6	17.4	21.0	1.1	1.9	15.1	2.7	1.0	37.8	0.0	0.9	1.1	6.9	6.5	1.0	1.0	0.9	15.7	8.0	1.1	2.7	3.0	1.7	28.8	9.3	0.7	0.8	0.6	0.2	2.8	13.9	2.0	0.8	0.7	1.3	1.4	1.4	25.4	1.0	0.9	26.2	11.6	0.9	0.9	21.0	0.0	0.8	0.2	3.3	3.1	5.0	0.1	0.1	0.8	0.1	8.1	62.0	10.2	1.4	2.2	0.4	0.0	0.0	0.1	0.1	0.5	0.3	0.6	0.4	0.2	0.1	0.0	5.9	0.2	21.5	1.4	8.3	1.6	0.0	1.4	0.2	1.7	0.0	0.0	0.0	0.1	0.0	3.9	2.3	0.4	0.0	0.1	0.0	0.0	2.7	0.8	0.0	3.4	0.4	0.0	1.6	0.0	0.0	14.0	0.0	0.0	3.5	0.0	0.4	8.9	2.5	0.0	1.1	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.2	62.0	0.0	38.0	0.1	7.8	29.2	0.1	0.1	2.4	23.2	0.8	8.1	0.1	0.1	0.1	10.2	10.0	17.4	1.9	15.1	15.7	8.0	28.8	9.3	13.9	21.0
FLT3LG		ENSG00000090554	"Fms related tyrosine kinase 3 ligand"	P49771	19	49474207-49486231	"Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.6;U-266/70: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdTCR: 18.2;MAIT T-cell: 33.7;memory CD4 T-cell: 37.3;memory CD8 T-cell: 23.7;naive CD4 T-cell: 41.1;naive CD8 T-cell: 32.0;T-reg: 35.9"	"Lineage enriched"	"Detected in all"	7	"T-cells: 41.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (1.29e-3)"	"prognostic favourable (2.17e-5)"	"unprognostic (2.12e-3)"	"unprognostic (9.16e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.78e-6)"	"unprognostic (2.17e-1)"	"unprognostic (5.25e-2)"	"unprognostic (8.22e-3)"	"unprognostic (5.68e-2)"	12.8	5.9	4.5	21.0	6.7	14.0	11.1	1.9	4.0	14.1	12.4	5.1	6.6	9.4	12.1	8.0	11.3	9.2	14.8	6.8	3.4	2.7	8.6	4.8	10.5	32.7	4.3	2.6	16.3	4.5	2.2	5.7	3.5	4.7	12.9	3.4	6.6	9.6	7.7	7.1	8.8	11.0	10.8	4.9	17.0	8.1	5.5	6.3	49.8	8.5	9.0	32.7	11.6	16.0	3.1	1.2	4.9	6.0	6.0	41.1	10.4	4.2	0.4	0.6	1.5	7.1	11.7	0.4	3.2	6.7	6.9	11.5	0.3	4.6	4.1	1.7	4.5	4.6	1.1	3.7	1.7	17.6	1.7	3.0	1.7	1.6	12.4	2.7	10.4	7.9	0.5	4.7	0.9	2.3	1.3	13.9	2.0	2.6	2.8	4.4	0.2	0.8	2.2	2.1	4.7	1.0	2.6	0.3	1.0	1.0	1.2	1.9	1.7	2.1	2.0	8.7	1.9	5.1	4.7	17.6	5.4	1.7	4.3	5.7	2.4	1.1	1.6	4.9	18.2	4.5	33.7	3.1	37.3	23.7	1.2	2.6	41.1	32.0	1.7	6.0	6.0	0.5	35.9	10.4	4.5	6.7	1.9	4.0	3.4	2.7	4.3	2.6	4.7	6.3
PATL2	Pat1a	ENSG00000229474	"PAT1 homolog 2"	C9JE40	15	44665732-44711316	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.7;lymphoid tissue: 13.1"	"Cell line enriched"	"Detected in some"	28	"U-266/70: 53.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdTCR: 16.7"	"Lineage enriched"	"Detected in many"	7	"T-cells: 16.7"	"Low region specificity"	"Detected in some"																		"unprognostic (1.28e-2)"	"unprognostic (8.59e-3)"	"unprognostic (3.30e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.69e-4)"	1.4	2.3	0.6	5.6	1.3	5.2	1.1	0.4	1.2	0.9	1.3	0.4	0.4	1.5	1.1	1.4	2.1	1.3	5.1	1.6	1.1	0.5	1.4	1.5	4.7	12.7	2.0	1.3	1.3	0.7	0.0	1.7	1.0	1.0	1.7	1.7	1.2	4.8	0.4	1.0	1.8	6.5	0.4	1.8	13.1	2.0	1.0	1.5	0.9	1.4	0.4	8.4	2.2	0.9	2.5	0.5	1.7	0.4	1.7	16.7	2.2	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.1	0.3	0.4	0.2	0.5	0.3	0.0	0.1	0.5	0.0	0.1	0.2	0.8	0.0	0.5	0.0	0.0	0.2	0.2	0.3	0.5	0.0	0.2	0.1	0.0	0.0	1.8	0.1	0.1	0.0	0.5	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.2	0.1	0.0	0.3	0.0	53.0	1.6	0.1	0.5	1.2	0.1	1.0	0.2	1.7	16.7	0.4	2.4	2.5	4.7	13.0	0.5	2.4	2.8	10.1	1.1	1.7	0.3	0.4	0.6	2.2	0.6	1.3	0.4	1.2	1.1	0.5	2.0	1.3	1.0	1.5
BIRC5	"API4, EPR-1, survivin"	ENSG00000089685	"Baculoviral IAP repeat containing 5"	O15392	17	78214186-78225636	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.6;testis: 51.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 14.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 14.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA002830, CAB004270"	Enhanced		Supported	"Cytokinetic bridge"				"Cytokinetic bridge"		"CAB004270: AB_628302, HPA002830: AB_1857672"	"unprognostic (8.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (5.28e-6)"	"prognostic unfavourable (4.49e-4)"	"unprognostic (3.56e-3)"	"unprognostic (4.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	2.3	1.5	0.4	14.1	0.7	20.8	5.3	0.7	0.6	1.9	4.8	0.3	0.2	4.6	0.9	1.4	13.4	0.4	2.2	2.4	0.5	0.4	1.3	2.2	2.4	9.7	0.6	0.2	0.9	0.8	0.0	0.4	6.1	0.5	0.9	5.2	0.2	2.1	0.2	0.6	3.5	4.7	2.4	0.7	6.3	3.2	51.4	0.3	61.6	0.5	14.4	11.7	2.0	3.2	2.5	0.8	0.5	0.0	2.2	14.0	3.0	31.6	29.6	26.7	28.9	1.7	2.8	9.8	24.4	13.7	34.8	22.9	24.2	12.5	32.6	9.9	14.1	16.9	27.0	15.6	30.5	11.0	37.5	21.5	17.5	28.4	0.2	20.7	16.2	0.9	1.1	19.3	14.3	24.6	26.9	27.6	26.7	18.3	44.0	19.8	19.9	52.1	23.0	43.4	25.2	8.2	11.7	33.0	22.8	18.7	21.2	16.6	28.0	19.6	9.2	42.2	37.4	18.2	34.6	20.0	16.1	37.7	15.4	8.7	36.6	0.0	0.0	0.0	0.7	0.0	0.2	2.5	4.3	2.8	0.8	0.3	0.0	0.4	0.5	2.2	0.0	0.3	14.0	3.0	0.4	0.7	0.7	0.6	0.5	0.4	0.6	0.2	0.5	0.3
CD28		ENSG00000178562	"CD28 molecule"	P10747	2	203706475-203738912	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.7;lymphoid tissue: 48.6"	"Group enriched"	"Detected in some"	14	"Karpas-707: 72.1;RPMI-8226: 33.0;U-266/70: 59.3;U-266/84: 53.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 32.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 32.7"	"Region enhanced"	"Detected in single"		"olfactory region: 1.3"	"Low region specificity"	"Detected in all"			HPA070003	Enhanced									"HPA070003: AB_2686226"	"unprognostic (5.54e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.07e-5)"	"unprognostic (9.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.78e-5)"	"unprognostic (4.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-2)"	5.1	0.6	0.4	14.2	0.5	1.9	3.3	0.3	0.4	1.1	1.6	0.4	0.2	0.6	1.1	2.3	1.5	2.1	3.0	4.5	0.4	0.5	1.7	1.5	3.8	23.3	0.5	0.2	1.4	0.6	0.0	0.6	11.0	0.2	1.2	1.3	1.2	3.1	0.8	0.7	1.0	7.2	0.9	0.8	9.0	1.6	0.9	0.0	48.6	1.5	0.8	29.9	4.5	1.4	0.1	0.0	5.1	0.2	0.0	32.7	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	72.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.3	53.0	0.5	0.0	0.0	0.0	0.5	0.2	0.3	3.0	0.1	18.2	0.1	19.4	9.5	0.0	0.1	17.0	6.5	5.1	0.0	0.1	0.0	32.7	4.7	0.4	0.5	0.3	0.4	0.4	0.5	0.5	0.2	0.2	0.0
CXCR6	"BONZO, CD186, STRL33, TYMSTR"	ENSG00000172215	"C-X-C motif chemokine receptor 6"	O00574	3	45940933-45948353	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 81.3"	"Group enriched"	"Detected in some"	6	"BEWO: 4.1;CAPAN-2: 15.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	4	"MAIT T-cell: 81.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 81.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (2.05e-3)"	"prognostic favourable (4.92e-4)"	"unprognostic (1.77e-3)"	"prognostic favourable (6.74e-6)"	"unprognostic (6.67e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-4)"	"unprognostic (8.57e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (2.42e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.57e-2)"	2.5	1.1	0.5	7.6	0.5	0.5	2.1	0.4	0.5	2.3	9.9	1.1	1.5	3.0	2.7	3.2	3.0	2.4	5.2	1.7	0.6	0.6	2.5	2.5	9.2	10.4	0.6	0.2	3.7	1.6	0.0	0.9	18.9	1.0	2.6	2.6	3.0	3.3	0.2	7.7	1.1	10.8	1.0	1.3	22.3	6.0	2.3	0.2	5.2	4.1	5.3	14.6	5.2	2.6	0.0	0.1	0.1	0.0	13.4	81.3	3.8	0.3	0.1	0.0	0.3	0.0	0.0	4.1	0.2	0.0	0.0	0.0	1.1	15.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.8	0.2	0.3	0.6	0.1	0.0	0.0	0.0	1.7	0.0	0.1	0.3	0.9	0.0	0.2	0.8	0.4	1.5	0.7	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.0	17.3	0.0	81.3	0.0	4.9	20.3	0.0	0.0	0.2	3.1	0.1	13.4	0.0	0.1	14.5	3.8	0.5	0.5	0.4	0.5	0.6	0.6	0.6	0.2	1.0	0.2
PIK3IP1	"HGFL, MGC17330"	ENSG00000100100	"Phosphoinositide-3-kinase interacting protein 1"	Q96FE7	22	31281593-31292534	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.0"	"Cell line enhanced"	"Detected in many"		"RT4: 14.0;SK-BR-3: 15.6;U-698: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 82.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 82.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									8600000	8600000				"unprognostic (1.02e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.65e-3)"	"unprognostic (4.42e-2)"	"unprognostic (8.68e-2)"	"prognostic favourable (3.80e-4)"	24.0	22.9	17.3	31.8	22.8	21.4	19.5	33.2	22.7	11.8	15.3	22.3	13.2	10.5	18.7	10.7	12.4	12.9	15.8	19.5	19.1	12.4	13.9	5.7	26.2	64.1	19.9	15.0	12.4	5.8	11.3	8.0	14.6	18.0	13.8	9.7	13.3	27.3	20.2	14.2	27.1	29.7	14.9	20.7	36.8	14.3	13.7	22.5	38.8	29.5	7.7	45.1	21.9	12.6	13.5	0.9	5.6	4.8	8.3	82.0	29.1	0.3	0.2	0.5	0.1	7.2	12.7	0.6	1.8	5.7	0.1	0.6	0.2	12.1	9.2	6.8	2.8	7.9	0.0	3.4	0.1	1.5	1.1	0.2	1.4	1.4	2.4	0.7	0.5	12.3	5.0	0.1	0.1	3.8	0.5	11.6	0.8	0.8	0.1	1.4	0.5	0.3	0.7	0.5	6.7	3.0	14.0	0.7	1.5	0.6	15.6	0.8	1.3	1.2	11.6	0.0	2.7	0.2	0.0	5.5	2.3	19.9	0.2	1.6	0.2	5.6	2.7	2.4	12.9	3.4	15.2	5.9	33.3	18.2	0.9	13.5	82.0	51.1	1.1	8.3	4.8	0.3	37.5	29.1	17.3	22.8	33.2	22.7	19.1	12.4	19.9	15.0	18.0	22.5
UTS2	"PRO1068, U-II, UCN2, UII"	ENSG00000049247	"Urotensin 2"	O95399	1	7843083-7853512	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 25.4;brain: 19.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 16.4;HEL: 5.7;HMC-1: 4.9;THP-1: 21.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	19	"hypothalamus: 5.2;pons and medulla: 19.8"	"Cell type enriched"	"Detected in many"	6	"T-reg: 25.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 25.4"									HPA017000	Uncertain				"Secreted to blood"					"HPA017000: AB_1858656"	"unprognostic (2.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.32e-5)"	"unprognostic (1.09e-4)"	"unprognostic (4.95e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.30e-3)"	1.0	6.3	0.3	0.6	0.3	5.2	0.3	0.3	0.3	0.5	1.2	0.4	1.2	1.1	0.3	0.3	0.3	0.6	0.9	0.3	0.6	5.2	0.3	0.3	0.6	2.9	0.3	0.3	0.4	0.3	0.0	0.3	0.3	19.8	2.0	2.4	0.3	0.3	0.3	0.3	0.5	1.0	2.3	12.7	2.1	0.2	0.3	0.3	0.6	0.3	0.3	0.3	0.9	0.3	0.0	0.4	4.1	0.0	3.2	25.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.1	0.0	0.3	3.0	0.0	4.0	0.0	2.7	2.8	0.4	0.0	0.2	0.8	0.0	3.2	0.0	0.0	25.4	0.9	0.3	0.3	0.3	0.3	0.6	5.2	0.3	0.3	19.8	0.3
AC008695.1		ENSG00000273217			5	131425891-131796983	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A549: 6.9;HL-60: 1.3;HMC-1: 2.7;U-937: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 11.1"									"HPA037982, HPA037983"	Uncertain		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: "																		4.0	2.5	3.6	2.4	4.3	3.8	2.9	3.4	4.1	2.7	2.7	3.8	2.1	2.4	3.5	2.4	2.5	2.5	2.4	2.6	2.5	2.5	2.5	2.5	2.6	3.5	5.8	2.6	4.0	2.5	2.4	6.1	4.5	3.5	2.5	2.4	1.4	2.5	2.4	4.2	2.5	2.5	3.0	3.3	2.5	2.5	4.2	5.2	2.4	2.5	1.1	2.4	3.0	4.0	2.0	0.3	2.3	0.9	2.4	11.1	2.8	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	1.3	2.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	1.6	0.0	0.6	0.9	2.3	3.3	0.4	5.7	1.4	3.6	3.8	0.3	2.0	11.1	5.0	0.6	2.4	0.9	0.0	2.8	2.8	3.6	4.3	3.4	4.1	2.5	2.5	5.8	2.6	3.5	5.2
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;lymphoid tissue: 59.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"CAB005862: AB_449204, HPA037708: "	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.2	1.3	0.4	22.1	0.6	19.7	2.0	0.6	0.6	2.6	5.8	0.5	0.9	5.9	0.9	1.3	17.1	0.3	2.2	1.0	0.4	0.2	1.4	1.8	2.4	17.8	0.4	0.4	0.8	0.6	0.0	0.4	3.8	0.8	0.9	5.5	0.7	2.7	0.4	2.1	5.0	8.1	1.3	0.7	11.2	4.2	1.2	0.4	59.9	0.5	8.0	19.1	2.1	5.0	2.3	0.8	1.2	0.6	0.5	10.9	1.4	41.0	28.2	42.0	20.2	0.9	1.4	16.1	19.7	10.6	40.8	37.7	36.5	12.4	41.0	10.2	7.8	30.2	30.5	13.5	33.8	18.0	50.1	24.4	16.1	30.8	0.1	12.9	24.0	0.7	0.6	23.9	15.0	18.8	15.2	15.9	17.9	19.5	46.8	18.3	26.1	12.6	31.7	38.7	17.0	8.9	8.1	9.1	13.0	17.5	7.9	13.4	13.8	8.7	7.3	16.4	16.9	14.7	51.2	11.6	7.7	30.8	7.9	19.6	33.1	0.0	0.6	0.9	0.6	0.4	0.2	1.6	1.9	3.1	0.8	2.3	0.2	1.0	1.2	0.5	0.3	0.2	10.9	1.4	0.4	0.6	0.6	0.6	0.4	0.2	0.4	0.4	0.8	0.4
BATF	"B-ATF, BATF1, SFA-2"	ENSG00000156127	"Basic leucine zipper ATF-like transcription factor"	Q16520	14	75522425-75547015	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 41.1;lymphoid tissue: 26.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 81.1;MCF7: 30.5;RT4: 19.1;SK-BR-3: 15.6;U-937: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"T-cells: 41.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA059588, HPA064962"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA059588: AB_2684074, HPA064962: AB_2685392"	"unprognostic (3.33e-3)"	"unprognostic (4.87e-3)"	"prognostic unfavourable (8.30e-4)"	"prognostic favourable (5.35e-6)"	"unprognostic (3.02e-2)"	"prognostic favourable (7.91e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.17e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavourable (3.74e-9)"	"unprognostic (4.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-1)"	"prognostic favourable (4.30e-4)"	4.9	1.3	0.9	15.8	4.7	13.8	7.6	0.2	1.9	2.8	2.8	0.2	1.0	2.0	1.3	1.4	2.6	1.9	7.0	3.1	1.0	0.7	1.9	3.0	7.9	20.2	2.1	0.2	1.6	1.6	0.5	1.2	3.7	1.9	5.2	1.1	1.0	6.0	8.3	0.9	2.8	8.0	2.6	2.7	26.6	5.7	0.7	1.9	6.2	2.7	3.4	23.1	10.4	7.3	7.1	9.0	5.0	8.9	6.4	41.1	8.4	1.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.1	0.0	1.8	0.0	0.3	2.7	2.2	8.4	0.0	0.0	0.0	0.0	0.0	0.4	2.3	0.0	30.5	1.0	6.6	0.0	0.0	0.2	0.0	1.4	0.0	19.1	0.0	0.0	0.0	15.6	0.6	1.4	4.2	0.0	0.0	0.0	1.0	0.0	7.6	8.0	0.0	0.0	22.5	0.0	1.2	8.9	2.7	19.6	4.9	15.4	7.1	21.4	25.1	9.0	5.2	8.6	18.1	5.0	6.4	4.2	1.0	41.1	8.4	0.9	4.7	0.2	1.9	1.0	0.7	2.1	0.2	1.9	1.9
CARD17	INCA	ENSG00000255221	"Caspase recruitment domain family member 17"	Q5XLA6	11	105092469-105101431	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 14.4;skin 1: 6.7"	"Cell line enriched"	"Detected in single"	6	"AN3-CA: 5.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"T-reg: 14.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.4"																				"unprognostic (1.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.41e-2)"		"unprognostic (7.05e-2)"	"unprognostic (4.26e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.51e-9)"	"unprognostic (1.07e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.21e-2)"	1.3	0.1	1.2	1.9	1.1	0.2	0.3	0.1	1.5	1.4	0.8	0.1	0.1	0.0	0.1	0.1	4.5	0.0	0.7	0.1	0.1	0.1	0.8	0.2	1.5	3.4	2.5	0.1	0.1	0.1	0.0	0.1	0.9	1.1	0.7	0.0	0.1	0.5	0.1	0.1	6.7	0.9	0.1	0.1	1.8	0.1	0.1	0.9	0.1	0.1	4.0	3.1	2.0	2.0	0.0	1.2	3.1	1.3	0.0	14.4	0.9	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.9	1.2	1.9	0.0	3.5	1.0	1.2	0.0	0.1	0.4	3.1	0.0	0.3	0.1	14.4	0.9	1.2	1.1	0.1	1.5	0.1	0.1	2.5	0.1	1.1	0.9
DUSP16	"KIAA1700, MKP-7, MKP7"	ENSG00000111266	"Dual specificity phosphatase 16"	Q9BY84	12	12474210-12562383	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 24.2;RT4: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020326	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA020326: AB_1847890"	"unprognostic (8.05e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.49e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.86e-2)"	"prognostic favourable (1.01e-4)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.76e-2)"	6.4	32.8	6.3	14.8	7.5	3.4	12.5	16.4	7.1	8.8	13.1	6.7	9.5	13.6	11.0	9.1	9.5	6.8	12.3	5.8	6.7	5.4	6.6	34.2	17.0	13.2	8.0	3.6	8.5	13.9	11.6	31.4	21.3	7.7	13.9	11.7	9.2	17.4	9.5	8.3	7.9	20.1	5.7	9.1	12.2	9.9	8.6	9.2	40.7	10.8	6.8	16.7	10.9	13.4	0.1	0.2	1.4	0.1	0.1	6.9	0.5	2.7	4.1	5.2	2.7	1.8	2.4	8.7	1.7	3.7	4.1	6.0	12.2	5.3	0.2	0.9	1.8	1.8	9.2	1.5	5.9	8.9	4.6	0.4	4.4	13.6	3.9	0.8	1.9	1.9	4.6	3.3	10.9	3.2	2.4	7.5	0.3	6.0	1.0	0.6	24.2	1.3	1.2	1.7	5.0	2.6	22.0	7.9	7.6	6.6	8.9	4.4	3.4	1.5	2.8	1.9	5.5	1.2	1.9	5.3	6.1	0.9	2.5	1.8	2.6	0.0	0.0	0.0	1.1	0.1	4.6	0.1	3.2	1.5	0.2	0.1	1.1	0.7	1.4	0.1	0.0	0.0	6.9	0.5	6.3	7.5	16.4	7.1	6.7	5.4	8.0	3.6	7.7	9.2
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293643	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.9;lymphoid tissue: 30.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (2.01e-5)"	"prognostic unfavourable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favourable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.7	0.4	0.2	7.1	0.4	7.2	0.3	0.2	0.5	3.9	2.3	0.4	0.8	4.2	0.6	0.7	17.9	0.2	0.5	1.0	1.1	0.1	1.0	0.9	0.7	4.1	0.2	0.2	0.3	0.2	0.0	0.2	3.0	0.6	0.4	1.5	0.6	2.6	0.2	0.2	2.7	4.4	0.5	0.2	3.0	0.8	10.9	0.3	30.3	0.3	2.5	7.8	0.7	6.2	0.0	0.0	0.4	0.1	0.0	1.8	0.0	12.4	12.7	13.7	11.2	0.3	1.2	8.4	8.2	4.2	14.1	9.0	6.9	11.0	22.5	4.6	3.3	10.4	15.8	4.8	7.4	7.0	16.0	15.1	11.5	5.3	0.0	9.4	12.5	0.4	0.3	8.2	4.0	7.2	20.2	20.4	4.2	13.0	14.8	8.1	11.0	6.9	13.9	14.6	9.3	2.0	5.2	9.8	7.6	6.9	10.2	5.3	16.8	6.3	3.3	7.1	13.8	6.0	11.2	15.1	14.0	15.2	4.1	8.9	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.8	0.0	0.2	0.4	0.2	0.5	1.1	0.1	0.2	0.2	0.6	0.3
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877288-88895626	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.4;lymphoid tissue: 23.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.6;U-2 OS: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 25.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			"Plasma membrane, Cytosol"		"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavourable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	9.9	1.3	1.1	20.6	2.7	4.4	8.7	1.0	2.3	5.3	2.6	1.1	0.3	1.4	4.4	4.9	5.7	6.0	4.7	9.8	3.2	1.0	3.0	0.8	8.7	23.6	3.1	0.9	5.2	2.3	0.9	2.2	2.7	3.6	5.2	1.1	3.2	6.4	1.6	4.2	6.0	4.1	4.7	6.2	6.9	3.6	1.9	1.8	5.7	7.2	7.6	10.9	6.0	5.6	0.8	1.1	0.7	0.6	4.8	25.4	3.2	1.2	4.3	0.9	9.6	2.7	3.0	3.0	2.6	0.6	1.0	1.3	2.7	4.0	0.0	7.6	3.3	1.0	9.1	1.2	0.0	20.6	8.0	3.0	0.2	0.0	0.4	0.0	0.1	1.1	0.5	1.9	0.1	4.5	0.0	5.9	0.4	0.1	0.0	0.0	7.1	0.1	0.0	0.4	7.2	1.8	0.1	0.1	2.6	0.5	0.5	3.6	0.0	0.3	0.8	6.9	20.6	5.2	0.4	0.9	0.0	0.0	2.5	0.0	5.9	0.7	0.6	0.0	0.6	0.3	3.0	0.1	10.0	4.1	1.1	0.8	10.2	4.5	0.1	4.8	0.1	0.4	25.4	3.2	1.1	2.7	1.0	2.3	3.2	1.0	3.1	0.9	3.6	1.8
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290090-70420832	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;lymphoid tissue: 19.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"									"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.9	0.6	0.8	3.3	1.0	11.1	0.5	0.4	3.4	1.2	4.1	0.4	0.4	3.4	0.8	0.4	7.4	1.5	2.5	2.0	0.8	1.3	0.7	0.7	1.5	5.8	0.5	0.9	0.4	0.4	0.0	1.3	2.4	0.8	0.7	5.2	0.4	1.2	0.4	0.8	2.3	3.6	1.2	0.5	4.9	2.1	7.5	1.1	19.3	0.4	0.4	7.2	1.1	2.0	0.7	0.0	0.0	0.2	0.2	3.2	0.3	22.4	15.7	23.8	11.7	1.1	2.0	9.4	17.1	9.2	23.4	20.4	17.6	13.2	13.8	10.8	8.4	13.5	25.7	9.3	26.4	15.8	12.9	15.6	19.2	12.5	0.2	17.3	10.9	0.6	0.5	19.4	11.1	14.3	19.8	30.8	22.0	14.4	15.8	8.6	24.0	16.7	17.6	32.1	13.0	5.6	8.9	15.7	13.1	27.9	11.8	7.3	9.5	6.8	9.9	15.5	20.2	16.6	20.3	8.9	15.2	20.0	8.2	19.1	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	3.2	0.3	0.8	1.0	0.4	3.4	0.8	1.3	0.5	0.9	0.8	1.1
MELK	KIAA0175	ENSG00000165304	"Maternal embryonic leucine zipper kinase"	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 4.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA017214	Uncertain									"HPA017214: AB_1853798"	"unprognostic (5.03e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (2.91e-7)"	"prognostic unfavourable (3.99e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (4.69e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (8.86e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.35e-1)"	1.5	1.1	0.3	11.4	0.6	7.7	2.6	0.2	0.8	2.1	5.9	0.3	0.1	4.5	1.2	1.5	12.2	0.4	1.6	1.3	0.5	0.4	1.2	1.3	2.0	8.3	0.4	0.1	0.7	0.8	0.0	0.3	6.3	0.5	0.7	7.8	0.4	2.3	0.1	0.9	2.8	4.6	1.9	1.0	5.2	2.9	11.3	0.4	42.4	0.5	7.2	12.6	1.5	3.3	0.1	0.6	1.0	0.1	0.4	4.8	0.5	35.4	18.2	24.6	14.5	3.4	5.9	14.3	26.3	18.6	36.9	45.6	14.0	14.0	11.9	8.5	12.9	12.2	21.4	16.5	40.8	32.3	8.5	9.3	21.7	13.9	1.3	14.4	11.8	2.1	3.0	28.5	16.2	18.6	11.9	19.0	30.2	11.8	17.9	6.8	19.6	14.3	16.6	16.6	7.6	11.3	12.0	16.7	12.4	14.0	13.5	8.5	11.3	6.9	9.1	19.9	25.2	16.8	23.9	3.7	13.5	17.8	12.6	10.7	27.0	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.8	1.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.6	4.8	0.5	0.3	0.6	0.2	0.8	0.5	0.4	0.4	0.1	0.5	0.4
NOS3	"ECNOS, eNOS"	ENSG00000164867	"Nitric oxide synthase 3"	P29474	7	150990995-151014588	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.2;HUVEC TERT2: 21.5;K-562: 7.6;TIME: 39.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 32.4;cerebral cortex: 12.4;hippocampal formation: 18.8;pons and medulla: 35.3"	"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	5	"T-cells: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002168	Enhanced									"CAB002168: AB_564072"	"unprognostic (6.53e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	11.4	4.5	3.1	7.5	32.4	1.9	25.6	1.8	12.4	4.6	3.2	1.7	1.0	4.0	8.3	2.5	4.7	5.0	6.6	35.2	18.8	3.4	5.5	5.4	14.0	10.3	4.7	1.7	4.5	4.1	2.7	4.8	11.5	35.3	5.2	2.5	5.2	3.0	3.2	6.0	4.9	4.0	5.4	25.9	70.6	3.6	4.5	1.6	0.0	5.9	2.1	2.4	5.1	7.3	1.1	0.5	0.7	0.4	0.5	5.3	1.2	0.2	0.0	0.6	1.9	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.1	1.0	0.2	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	1.0	0.1	2.9	0.3	0.2	5.0	0.0	0.1	0.0	0.0	21.5	7.6	1.8	0.0	0.0	0.1	0.2	0.8	0.0	1.4	0.0	0.8	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.1	0.6	39.2	0.1	0.4	0.1	0.0	1.2	4.0	1.0	0.0	3.5	0.0	0.3	0.3	0.2	2.5	0.4	1.5	0.8	3.9	2.2	0.5	1.1	5.3	2.1	0.7	0.5	0.4	0.5	4.4	1.2	3.1	32.4	1.8	12.4	18.8	3.4	4.7	1.7	35.3	1.6
OXNAD1	MGC15763	ENSG00000154814	"Oxidoreductase NAD binding domain containing 1"	Q96HP4	3	16265160-16350299	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 33.0"	"Lineage enriched"	"Detected in all"	5	"T-cells: 33.0"					"Low region specificity"	"Detected in all"			"HPA036830, HPA059160"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA036830: AB_2675338, HPA059160: AB_2683936"	"unprognostic (4.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.38e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.08e-2)"	"prognostic favourable (1.00e-7)"	"unprognostic (2.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-3)"	"prognostic favourable (7.63e-4)"	8.1	8.8	7.5	14.1	11.1	10.9	8.1	9.1	13.6	5.4	11.4	9.1	7.3	16.3	7.7	4.3	10.8	6.2	7.1	12.0	7.1	5.9	15.5	22.4	6.6	20.7	10.9	7.9	6.9	7.4	6.5	12.4	5.2	9.5	5.4	10.2	6.8	9.4	9.3	18.1	8.2	18.4	4.2	8.9	9.2	9.4	9.3	12.1	8.2	8.0	7.0	16.0	7.8	6.6	1.9	2.2	1.3	2.0	6.4	33.0	7.5	5.5	8.1	5.3	8.4	6.3	5.6	20.9	6.0	4.5	8.3	6.7	11.7	5.7	8.0	3.8	3.7	4.0	11.0	9.8	8.0	14.4	7.3	11.7	7.0	6.2	6.5	18.8	7.1	4.2	7.4	13.5	6.5	6.4	15.9	19.1	3.6	9.9	10.9	9.9	11.3	9.6	9.8	6.5	13.9	5.6	6.7	3.8	5.3	6.7	11.3	9.3	7.2	10.9	2.9	5.4	6.9	5.9	9.7	6.9	12.5	12.9	6.5	16.5	7.2	0.0	1.4	1.1	9.0	2.0	11.9	1.9	13.8	9.7	2.2	1.5	33.0	24.4	1.3	6.4	1.8	1.7	7.3	7.5	7.5	11.1	9.1	13.6	7.1	5.9	10.9	7.9	9.5	12.1
PCLAF	"KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15"	ENSG00000166803	"PCNA clamp associated factor"	Q15004	15	64364311-64387687	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 42.1;lymphoid tissue: 78.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"T-reg: 24.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 24.2"									HPA047929			Supported	Centrosome				Centrosome		"HPA047929: AB_2680215"	"unprognostic (5.34e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (4.38e-3)"	"unprognostic (1.91e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.56e-3)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (9.77e-15)"	"unprognostic (5.59e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.22e-1)"	2.1	1.8	0.7	24.5	0.8	42.1	2.6	0.4	0.8	1.8	7.7	0.6	1.0	4.6	1.6	2.8	18.8	0.6	4.0	2.2	0.8	1.0	2.5	3.0	4.0	21.8	1.4	0.4	0.9	1.4	0.1	0.6	5.1	0.7	1.6	10.1	0.5	3.1	0.4	0.9	2.8	8.1	1.6	1.9	10.9	4.9	3.0	0.5	78.3	1.2	18.0	20.7	4.3	5.7	2.2	3.2	2.0	0.4	5.2	24.2	2.7	30.4	35.2	30.0	19.1	3.1	11.3	21.9	23.5	20.9	45.3	65.8	39.5	29.0	58.5	8.4	11.9	22.9	74.7	18.2	51.3	37.1	26.8	57.3	37.1	34.0	0.3	37.7	21.2	3.8	1.9	35.8	7.2	34.4	35.2	21.5	52.1	35.1	45.6	84.6	11.1	15.3	59.6	56.8	38.4	21.5	31.5	2.9	15.4	18.6	14.8	10.8	20.9	52.4	4.8	22.5	47.2	27.2	62.7	11.7	40.6	36.6	9.3	83.2	15.1	2.0	0.2	1.2	1.6	0.1	0.2	2.2	4.8	4.5	3.2	0.5	0.4	0.8	1.6	5.2	0.4	0.2	24.2	2.7	0.7	0.8	0.4	0.8	0.8	1.0	1.4	0.4	0.7	0.5
PIF1	"C15orf20, FLJ22692"	ENSG00000140451	"PIF1 5'-to-3' DNA helicase"	Q9H611	15	64815632-64825668	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.3"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 10.2"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			CAB018701	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB018701: AB_2164654"	"unprognostic (1.99e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.33e-3)"	"unprognostic (8.66e-4)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (5.22e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.27e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.95e-2)"	1.8	1.1	0.6	12.9	0.6	6.0	0.6	0.6	1.2	1.2	5.2	0.6	0.6	3.3	2.0	1.3	4.6	0.8	1.4	0.9	0.6	1.8	0.7	0.6	1.9	7.5	0.9	0.6	0.6	0.6	0.0	0.6	1.4	1.0	2.5	1.8	0.9	0.8	1.2	0.6	1.6	3.7	2.1	0.6	7.0	2.7	3.3	0.6	14.3	0.6	5.1	6.0	1.8	1.9	0.7	0.3	0.0	0.0	0.0	3.2	0.4	5.1	6.0	14.7	5.9	2.6	3.1	5.4	5.1	2.7	5.1	4.0	9.5	8.6	6.2	2.1	2.5	14.3	15.1	4.3	1.9	9.9	5.5	7.2	16.9	6.8	1.3	2.9	5.9	1.7	0.0	2.2	1.8	5.2	4.7	12.5	4.8	4.5	3.0	12.0	12.0	4.2	6.4	4.9	8.7	2.8	2.9	6.1	3.9	3.9	4.3	2.3	4.8	3.1	3.5	3.1	16.1	4.9	9.3	10.1	9.3	5.9	2.9	12.7	4.4	0.0	0.0	0.0	1.5	0.0	0.5	0.7	0.1	1.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.3	3.2	0.4	0.6	0.6	0.6	1.2	0.6	1.8	0.9	0.6	1.0	0.6
PLK1	PLK	ENSG00000166851	"Polo like kinase 1"	P53350	16	23677656-23690367	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 83.9;testis: 32.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"T-reg: 9.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 9.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA051638, HPA053229"	Approved									"HPA051638: AB_2681561, HPA053229: AB_2682084"	"unprognostic (7.21e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavourable (2.70e-7)"	"prognostic unfavourable (2.28e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (4.12e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.33e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-2)"	2.9	1.1	1.1	14.2	1.5	15.9	1.7	2.1	1.1	1.5	7.1	0.7	0.5	6.0	1.1	0.9	10.4	0.7	1.5	1.0	1.0	0.8	1.3	1.2	2.6	15.2	0.8	0.6	1.2	0.7	0.0	0.8	6.8	0.7	0.9	5.9	0.5	1.7	0.8	0.8	2.9	5.9	2.0	0.7	8.3	3.6	32.4	0.5	83.9	0.6	6.6	20.4	2.1	2.6	1.9	0.5	0.7	0.1	1.3	9.0	2.3	43.1	45.0	37.2	20.2	1.1	2.6	20.9	24.7	16.3	38.7	28.9	39.3	28.5	21.6	12.9	16.6	24.8	50.7	20.3	46.6	30.7	28.6	27.4	35.5	53.7	0.3	31.6	30.1	1.0	1.1	27.4	28.3	28.3	42.6	29.8	29.8	39.4	29.7	31.6	42.5	22.9	46.5	25.3	34.3	11.0	9.4	21.0	14.6	28.2	19.8	12.8	25.2	19.5	14.3	18.4	23.6	18.0	42.1	21.2	33.0	37.4	15.6	27.5	30.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	1.4	0.5	0.5	0.0	0.0	0.0	0.7	1.3	0.0	0.0	9.0	2.3	1.1	1.5	2.1	1.1	1.0	0.8	0.8	0.6	0.7	0.5
TMEM204	"C16orf30, CLP24, FLJ20898"	ENSG00000131634	"Transmembrane protein 204"	Q9BSN7	16	1528688-1555580	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.5;BJ: 10.1;BJ hTERT+: 13.7;fHDF/TERT166: 9.1;HHSteC: 24.8;HSkMC: 9.9;TIME: 7.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 44.7"	"Lineage enriched"	"Detected in many"	5	"T-cells: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014028	Approved									"HPA014028: AB_2204906"	"unprognostic (1.51e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.81e-2)"	"prognostic favourable (4.76e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (7.89e-4)"	"unprognostic (8.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.62e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.53e-2)"	36.4	12.9	3.7	9.6	6.2	0.6	33.4	2.9	6.6	20.2	11.5	3.4	9.0	5.9	17.1	11.4	11.5	10.5	13.9	19.8	4.2	3.3	24.3	12.6	29.6	22.9	5.3	6.2	11.5	9.2	3.4	6.4	11.6	5.5	14.6	2.9	18.4	7.7	13.9	13.9	7.6	11.8	10.5	3.4	12.3	9.3	7.8	4.7	4.2	21.0	12.2	9.8	12.1	14.2	0.4	0.5	0.8	0.2	8.2	44.7	12.1	0.0	0.1	0.6	0.1	5.0	8.5	0.1	10.1	13.7	1.7	1.7	0.4	0.0	0.1	0.1	9.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.1	24.8	0.0	0.0	9.9	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.4	0.0	0.1	0.0	0.1	0.3	0.2	0.3	0.0	1.1	0.0	0.0	7.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.1	0.0	6.8	0.2	12.6	0.1	22.3	15.3	0.5	0.4	44.7	22.9	0.8	8.2	0.2	0.1	9.4	12.1	3.7	6.2	2.9	6.6	4.2	3.3	5.3	6.2	5.5	4.7
TROAP	TASTIN	ENSG00000135451	"Trophinin associated protein"	Q12815	12	49323236-49331731	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.3;lymphoid tissue: 45.6;testis: 29.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044102	Uncertain									"HPA044102: AB_10963691"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (3.43e-3)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.17e-2)"	0.7	1.3	0.3	17.3	0.4	26.3	2.6	0.4	0.9	2.1	6.5	0.5	0.3	5.1	0.8	2.5	11.2	0.5	3.2	1.9	0.4	0.2	1.2	1.3	2.0	6.2	0.3	0.5	0.8	0.8	0.0	0.5	4.3	0.7	0.9	5.5	0.6	2.2	0.8	0.7	4.3	5.2	1.4	0.4	5.9	4.0	29.1	0.3	45.6	0.7	7.0	10.8	1.1	4.1	2.0	0.4	0.2	0.1	2.3	10.9	0.9	26.2	20.8	27.2	19.9	0.8	2.0	20.4	12.8	12.7	38.6	22.1	46.1	20.8	18.0	6.3	9.8	21.0	21.2	12.5	22.5	14.5	29.0	25.1	33.0	14.9	0.5	18.2	27.0	0.4	1.7	25.7	17.6	21.8	15.5	31.1	15.5	34.0	33.4	28.0	12.5	31.5	17.2	22.7	23.3	9.2	9.8	17.3	11.9	15.8	30.5	9.6	25.0	13.8	6.9	9.8	26.9	19.8	34.5	16.8	18.2	22.5	9.4	20.5	10.9	0.2	0.0	0.1	0.2	0.0	0.4	2.0	2.9	3.0	0.4	1.5	0.1	0.7	0.0	2.3	0.1	0.0	10.9	0.9	0.3	0.4	0.4	0.9	0.4	0.2	0.3	0.5	0.7	0.3
CCR5	"CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22"	ENSG00000160791	"C-C motif chemokine receptor 5 (gene/pseudogene)"	P51681	3	46370854-46376206	"CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5"	"Group enriched"	"Detected in some"	17	"Karpas-707: 11.8;U-266/84: 5.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 24.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 24.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (4.32e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.89e-3)"	"prognostic favourable (7.42e-5)"	"unprognostic (1.80e-2)"	"prognostic favourable (9.33e-5)"	"unprognostic (3.38e-3)"	"unprognostic (9.90e-3)"	"unprognostic (7.65e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.14e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.42e-2)"	7.1	2.3	3.4	13.8	6.1	0.8	2.1	0.8	2.5	2.3	3.0	3.0	0.8	3.8	3.7	4.0	2.6	2.6	5.0	3.6	1.6	2.0	2.7	3.0	9.3	11.9	8.1	0.5	3.0	2.1	0.4	1.9	1.2	4.0	2.8	3.8	3.5	4.4	2.5	0.8	1.1	7.2	2.9	6.1	14.6	6.0	0.9	5.9	2.0	2.6	1.5	13.9	5.7	2.0	0.3	5.5	5.6	2.1	3.2	24.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.4	5.0	0.0	0.0	0.3	0.0	5.6	1.1	0.0	6.7	2.1	24.5	0.3	2.9	9.7	5.5	0.0	0.3	2.6	0.3	3.2	0.0	5.2	4.5	1.5	3.4	6.1	0.8	2.5	1.6	2.0	8.1	0.5	4.0	5.9
F2R	"CF2R, PAR-1, PAR1, TR"	ENSG00000181104	"Coagulation factor II thrombin receptor"	P25116	5	76716043-76735781	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.5"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 71.1;WM-115: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdTCR: 17.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 17.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008973, CAB012962"	Approved									"CAB008973: , CAB012962: AB_2533198"	"unprognostic (3.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.55e-2)"	"unprognostic (7.76e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (2.21e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.74e-3)"	12.3	11.2	1.5	7.5	2.2	1.1	8.9	0.8	3.5	11.7	14.0	3.3	20.1	5.9	17.6	8.6	9.3	3.5	20.8	19.2	1.4	1.7	19.5	22.6	24.4	10.4	1.5	1.8	6.2	4.0	1.6	4.7	32.0	2.5	9.6	5.1	9.6	26.4	14.0	7.2	23.7	15.5	8.4	3.5	67.5	4.5	16.6	1.4	4.0	9.1	11.4	13.5	10.7	4.7	0.4	0.2	0.8	0.3	4.2	17.6	6.4	1.0	3.3	10.4	1.7	19.8	34.6	0.5	5.8	19.9	3.8	13.9	0.7	9.1	0.0	9.9	2.4	2.5	4.4	3.5	7.3	0.8	3.7	22.7	0.7	2.8	29.9	0.1	0.9	19.5	11.8	7.3	2.0	71.1	4.2	4.3	7.8	0.4	1.7	0.0	3.3	18.2	3.2	6.2	0.8	18.0	0.1	1.2	5.6	1.7	0.0	8.5	0.1	0.2	32.5	24.2	5.4	0.2	10.7	11.6	3.4	0.0	6.4	0.4	67.0	0.5	0.2	0.3	17.6	0.3	4.4	0.4	4.1	12.1	0.0	0.1	0.7	9.1	0.8	4.2	0.1	0.2	0.4	6.4	1.5	2.2	0.8	2.1	1.4	1.7	1.5	1.8	2.5	1.4
KIR3DL1	"AMB11, CD158E1, CD158e1/2, CD158e2, cl-11, cl-2, KIR, nkat3, NKB1, NKB1B"	ENSG00000167633	"Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1"	P43629	19	54816468-54830778	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.4;bone marrow: 2.0;lymphoid tissue: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	4	"gdTCR: 5.4"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.4"																				"unprognostic (3.18e-1)"	"unprognostic (8.01e-2)"		"unprognostic (3.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (5.18e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.19e-2)"	0.1	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0			0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.1	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	5.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.5										
NCR3	"1C7, CD337, LY117, NKp30"	ENSG00000204475	"Natural cytotoxicity triggering receptor 3"	O14931	6	31588895-31592985	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 28.5;lymphoid tissue: 18.5"	"Cell line enriched"	"Detected in some"	4	"NB-4: 9.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 28.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 28.5"																				"unprognostic (3.99e-3)"	"unprognostic (9.23e-4)"	"unprognostic (1.23e-3)"	"unprognostic (2.49e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.43e-1)"	1.8	0.1	0.2	10.5	0.2	4.3	0.3	0.1	0.1	0.1	0.4	0.0	0.0	0.2	0.3	0.5	0.9	0.2	0.3	1.2	0.6	0.1	0.5	1.3	3.9	11.4	0.2	0.0	0.5	1.1	0.0	0.1	0.8	0.1	0.3	0.3	0.1	8.4	0.4	0.1	0.3	5.8	0.2	0.2	18.5	0.4	0.8	0.0	3.6	0.4	0.1	12.8	1.0	0.3	6.1	0.0	0.1	0.2	6.4	28.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	10.5	0.0	28.5	6.1	1.2	5.2	0.0	4.4	0.5	3.3	0.1	6.4	0.2	0.0	1.7	2.5	0.2	0.2	0.1	0.1	0.6	0.1	0.2	0.0	0.1	0.0
ZNF101	"DKFZp570I0164, HZF12"	ENSG00000181896	"Zinc finger protein 101"	Q8IZC7	19	19668796-19683509	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.4;lymphoid tissue: 37.9"	"Cell line enhanced"	"Detected in all"		"U-698: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 27.4"									"HPA023449, HPA055486"	Uncertain									"HPA023449: AB_2671211, HPA055486: AB_2682831"	"unprognostic (5.05e-2)"	"prognostic favourable (5.76e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.15e-4)"	"unprognostic (2.43e-1)"	"prognostic favourable (6.65e-4)"	"unprognostic (1.62e-2)"	"prognostic favourable (2.26e-4)"	"unprognostic (9.34e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.84e-3)"	"prognostic favourable (1.11e-4)"	"unprognostic (3.15e-2)"	"unprognostic (7.02e-2)"	"prognostic favourable (4.37e-4)"	4.0	2.5	2.8	21.6	2.7	9.7	5.6	2.7	2.9	2.7	3.7	2.2	2.3	2.5	3.2	2.3	8.1	2.0	4.4	2.2	3.2	2.4	4.0	3.0	4.0	36.0	2.8	1.9	2.7	3.6	1.5	2.5	4.2	2.2	2.5	3.8	3.9	7.0	3.1	1.5	4.2	8.1	1.6	3.1	11.0	3.5	11.3	2.1	37.9	4.5	4.3	22.1	5.4	3.1	6.8	4.8	5.4	3.3	4.8	27.4	7.7	3.0	2.8	3.5	4.1	1.3	2.4	6.2	3.6	1.9	2.8	4.9	3.5	3.7	17.3	3.9	1.8	2.7	6.0	3.6	5.6	2.5	3.2	5.5	2.6	5.6	1.1	10.0	9.4	1.8	2.1	5.0	3.7	3.3	3.8	9.8	3.2	3.5	12.7	3.2	9.1	4.3	5.0	4.5	7.3	2.9	5.0	1.7	1.9	3.3	2.8	1.2	3.7	6.0	2.5	3.9	1.5	5.9	3.5	4.6	9.0	40.5	2.3	5.4	3.6	5.4	2.0	3.4	6.5	2.7	11.5	6.8	15.5	10.2	3.0	6.4	22.2	16.1	3.0	4.8	3.3	4.8	27.4	7.7	2.8	2.7	2.7	2.9	3.2	2.4	2.8	1.9	2.2	2.1
